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Abstract 
The 2015 series of RIO Country Reports analyse and assess the policy and the national research and innovation 
system developments in relation to national policy priorities and the EU policy agenda with special focus on ERA 
and Innovation Union. The executive summaries of these reports put forward the main challenges of the research 
and innovation systems. 
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Foreword 
The report offers an analysis of the R&I system in Czech republic for 2015, including 
relevant policies and funding, with particular focus on topics critical for EU policies. The 
report identifies the main challenges of the Czech research and innovation system and 
assesses the policy response. It was prepared according to a set of guidelines for 
collecting and analysing a range of materials, including policy documents, statistics, 
evaluation reports, websites etc. The quantitative data is, whenever possible, 
comparable across all EU Member State reports. Unless specifically referenced all data 
used in this report are based on Eurostat statistics available in February 2016. The 
report contents are partly based on the RIO country report, 2014 (Srholec, 2015a). 
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Executive summary  
Context 
In 2014, gross domestic product (GDP) per capita in purchasing power standards 
reached €23,200, 85% of the EU28 average. After the real GDP dropped in the peak of 
the crisis, the economy somewhat recovered but plunged to double-dip recession, 
however, recent figures indicate that GDP growth has gained momentum.  
The Czech Republic is one of the most industrialised Member States. Its main 
manufacturing industries are automotive, mechanical engineering, electrical engineering, 
and electronics (RIS3 2014).  
The Reform of the Research, Development and Innovation (RDI) System was launched in 
2008. The main success area lies in the upgrading of research infrastructures, while the 
progress has been slow in promoting excellence, opening the research labour market, 
reforming the evaluation framework and getting ideas to market.  
Despite the economic crisis and major slowdown of economic growth, R&D intensity of 
the economy in terms of gross domestic expenditure on R&D (GERD) as % of GDP 
increased from the bottom 1.24% in 2008 to 2.00% in 2014 (Eurostat, 2015). Since 
2011 public funding slightly predominates over the private one but mostly through the 
intensive use of the Structural Funds. Business and foreign R&D funding, including from 
the EU Structural Funds, grew rapidly over the recent years, while national public 
funding of R&D has been stagnating in the recent years.  
Key developments in the R&I system in 2015 included: 
 The the Section for Science, Research and Innovations section started operation at the 
Office of the Government. 
 Technology Agency launched the EPSILON programme supporting applied research 
and experimental development in three priority areas of competitive knowledge-
based economy, sustainability of energy and material resources and environment 
for quality of life, while Ministry  of Trade and Industry approved the TRIO 
programme to support business R&I and public-private research collaboration in 
key enabling technologies 
 The new Operational Programmes of the EU Structural Funds were launched 
 Metodika 2013 guidelines for evaluation of public R&I support were extended until 
the end of 2016, while new guidelines are expected to be put in place in the 
period 2017 onwards. 
 The IPN Metodika project proposed a new methodology for evaluation of research 
organizations and principles for allocation of institutional funding  
The Czech R&I system is aligned with many ERA policies but it would benefit from larger 
extent of internationalisation. There are restrictions on access to and portability of grants 
as public funding agencies support almost exclusively resident researchers. Open access 
to both scientific publications and data for research purposes hinges on underdeveloped 
infrastructure and institutional framework. 
In 2008, a comprehensible reform of the RDI system was launched refocusing the policy 
measures on innovation and private-public research linkages. Business investment in 
research and innovation is not only supported by direct subsidies anymore, which used 
to be the dominant policy measure but by much broader portfolio of instruments, 
including R&D tax credits, support programmers for joint public-private research projects 
or regional innovation voucher programmes. Nevertheless, RDI policies continue to be 
focused predominantly on the supply side and are rooted in the linear model of 
innovation.  
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The identified challenges for the Czech's R&I system are: 
1. Improving the research excellence and internationalisation of Czech science 
system  
2. Finalising the governance reform and introducing an efficient system of allocation 
of public research funding 
3. Strengthening the public-private collaboration 
4. Increasing the innovativeness of domestic companies 
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R&I Challenges 
Challenge 1 Improving the research excellence and internationalisation of 
Czech science system  
Description 
Czech Republic has increased its public funding to R&D considerably from 0.56% in 2008 
to 0.87% in 2014 but mostly due to the increase of the EU Structural funds devoted to 
R&D. On the output side, however, the Czech Republic is still lagging behind as regards 
to the scientific excellence. It has close to the EU-28 average number of international co-
publications (37.6% with 2013 reference year) and only 5.7% of Czech scientific 
publications were among the 10 % of publications most cited worldwide (2000-2013, 
fractional counting). Also in the excellence indicator the Czech Republic has only little 
improved its scores between 2008 and 2012, virtually no progress has been made 
towards increasing the number of PCT patents and highly cited publications. Similarly to 
other countries of the 2004 accession, the Czech Republic FP7 funding share decreased 
as compared to FP6 and is now at 27.3€/inhabitant higher than the EU13 average of 
17.8 €/inhabitant but significantly lower that the EU15 average of 95.2€/inhabitant (StE 
2015). The Czech Republic ranks among countries with the greatest share of non-mobile 
researchers (including transfers inside the country), a share of more than 50% as 
compared to around 30% in the UK, Sweden or Belgium (Science Europe 2013), whereas 
mobility is an important factor of increasing research excellence. 
Policy response 
One of the objectives of the updated national RDI policy from 2013 is to stimulate 
research excellence and internationalization. Also the Smart Specialisation Strategy from 
2014 underlines their importance for the Czech research system. The Czech Republic has 
designed several instruments supporting the Czech researchers in participation in the EU 
programmes, EUPRO II being the largest programme, aims at increasing Czech 
participation in international R&D programs and bilateral activities. The RETURN 
programme (2009-2019) with €17M of the total budget supports the leading Czech 
scientists willing to come back the Czech research organisations after a period spent 
abroad. The new Operational Programmes foresee instruments supporting Czech teams 
applying for Horizon 2020 funds and other EU-level funding measures.  
Still, the main funding instrument of the Grant Agency of the CR (basic science funding 
agency) is a standard grant project, to which are allocated nearly three-quarters of the 
budget thus about €97m in 2014. Projects aimed at excellence in basic research started 
only in 2011 and received 17% of the budget, junior grants (started in 2014 and 
replaced postdoctoral grants) got 11% of the funding and international bilateral grants 
amount to 1% of the total funding. The interim methodology of institutional funding 
allocation is already taking into account the excellence by awarding additional points for 
the awardees of the ERC grants. The Czech Republic has also significantly invested in 
research infrastructures (cf. National Roadmap of the Czech Republic of Large 
Infrastructures for Research, Experimental Development and Innovation for the years 
2016-2022) also with the aim to attract foreign researchers. 
Policy Assessment 
The current public funding allocation system tends to spread thinly the resources with 
limited incentives for research excellence and therefore fails to achieve critical mass. 
There are limited financial incentives (RETURN programme) and no regulatory policy 
measures that encourage brain circulation and opening up of the Czech research system. 
The attractiveness of the new research infrastructures might need to be coupled with 
other soft measures in order stimulate foreign and local researchers to seek employment 
in the regions where those infrastructures are located.   
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Challenge 2 Finalising the governance reform and introducing an efficient 
system of allocation of public research funding 
Description 
The reform of the structure of the public RDI system commenced in 2008. The Council 
for R&D and Innovation (CRDI) has gradually become the central policy actor with 
increasing competencies and the Technology Agency of the Czech Republic (TA CR) was 
created to allocate funding for applied research, experimental development and 
innovation on competitive basis whereas the competitive funding for basic science is 
channelled through the Grant Agency of the CR. Nevertheless, the Ministry of Education, 
Youth and Sports (MEYS) and the Ministry of Industry and Trade still manage, through 
different intermediaries, the Operational Programmes (OP) of the EU Structural Funds. It 
results in overlapping roles of the Ministries (e.g. similar knowledge transfer 
programmes managed by the Ministry of Industry and Trade and by the Technology 
Agency of the Czech Republic – see challenge 3), coordination problems as well as 
fragmentation of funding. The Czech Republic was also subject of the Council 
recommendation for stalling its civil service reform. The lack of legislation (implemented 
only in mid-2015) resulted in high turnover of employees of public administration and 
problems with building capacity necessary for implementation and evaluation of R&I 
strategies. Moreover, the reform of the system for allocation of institutional funding is 
long overdue. The changes in the evaluation system were subject to the Council 
Recommendations in 2011- 2014.  
Policy response 
Pavel Bělobrádek, the Deputy Prime Minister for the Science, Research and Innovation 
announced the plans to form a new Ministry for Research and Innovation in August 
2015. A new law on Support for Research, Development and Innovation is under 
preparation that should clarify the status of the Ministry and improve the coordination in 
the system. The Czech Agencies for Basic Research and Applied Research will have a 
joint budget to streamline the funding efforts. The government recently approved a 
creation of a new funding Agency for Entrepreneurship and Innovation replacing the 
CzechInvest agency in disbursing the EU funds that are under the responsibility of the 
Industry and Trade Ministry. The adoption of the Civil Service Law is aimed inter alia to 
decrease the high turnover of civil servants and enhance the analytical capacities of the 
public administration. 
The Government is preparing a new system of evaluation of the results of research 
organizations and their institutional public funding. For the transition period 2013-2015 
the Government on 19th June 2013 approved the interim methodological guidelines 
based on a combination of peer review and quantitative evaluation based on research 
outputs including commercialisation of public research results. The IPN METODIKA 
project designed a new system of evaluation of research organisations and allocation of 
institutional funding. Pilot testing of the new methodology has been conducted in 2015. 
Based on those experiences, a new methodology of evaluation of research organizations 
will be proposed in 2016 and implemented not earlier than 2017. 
Assessment 
The concentration of the RDI policy under the new Ministry is a way to increase the 
coordination between the RDI policy and its implementation in various agencies. 
However, the exact role of the Ministry is still not clear, e.g. if the higher education and 
innovation will be under the competences of the new body. The new addition to the 
system, the Agency for Entrepreneurship and Innovation operational in 2016 will even 
increase the number of actors. The first results of the long awaited reform in evaluation 
of public funding will be seen only in 2017 but the intermediate methodology with the 
independent peer-review already introduces more balance to the system based 
previously solely on quantitative indicators.   
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Challenge 3 Strengthening the public-private collaboration 
Description 
The level of privately-funded public R&D expenditure in Czech Republic is very low 
(€38m in 2014 (one of the lowest in the EU-28). In 2014 it was only 1.23% of the total 
GERD. What is even more worrying this indicator displays a declining trend since 2000. 
Also the share of public-private co-publications is low (just about 1% compared to the 
EU-28 average of 2.2%, RIO calculations based on Scopus, 2015). The patenting activity 
of public research organisations has grown in the recent years (from 47 patents granted 
or receiving validation from the Czech Industrial Property Office in 2008, to 144 in 2011 
and 190 in 2012)1 but the general international patenting activity is increasing much 
slower (EPO registered 167 patent applications in 2014 (10.6% growth compared to 
2013) and granted only 66 patents in the same year while PCT patents numbers are 
even decreasing. The RIS3 strategy recognizes also the low application relevance of 
public research which is evidenced by a mismatch between fields with high-impact 
publications and patenting activity (RIS3 2014). 
Policy measures 
In April 2013, the national research, development and innovation (RDI) policy for 2009-
15 was updated and its stress on knowledge transfer and the innovative capacity of the 
business sector was reinforced.  
The Technology Agency of the Czech Republic (TA CR), created in 2009 to support 
applied research and science-business cooperation designed programmes to support 
knowledge transfer. ALFA, Competence Centres, DELTA and EPSILON programmes 
emphasise as one of their main goal promote collaboration of enterprises with public 
research organisations. GAMA programme of TA CR (€69m 2014 -2019) was specifically 
designed to support the verification of R&D results in terms of their practical application 
and their subsequent commercial use.  
At the same time, the Ministry of Industry and Trade continued the TIP programme, 
similar to ALFA in 2009-12, and Innovation programme targeted at knowledge transfer. 
In 2015 it introduced a new programme supporting applied research and cooperation, 
TRIO targeting also public-private collaboration.  
CzechInvest (the MIT executive agency) Innovation programme supports knowledge 
transfer and PROSPERITY programme  the creation of science and technological parks, 
TTOs and business angels networks. Many regional governments have implemented 
innovation voucher programmes  
Since 2014 the tax credits that enable enterprises to deduct R&D expenditures from their 
tax base have been extended to the purchase of external R&D services from research 
organisations, a policy measure aimed directly at stimulating industry-academia 
collaborations. Seed fund programmes for researchers are foreseen in the new 
Operational Programme: Enterprise and Innovations for Competitiveness. 
Assessment 
The current weak Czech Republic performance may be attributed to still low incentives 
for researchers to commercialise its results (see challenge 2) as well as low 
innovativeness of the business sector (challenge 4). The first results of the evaluation 
reform may be expected in 2015-2016 as the interim methodology already takes into 
account patents while evaluating the performance of public research institutions. The 
new tax credit may increase the volume of privately financed public performed R&D and 
the effects should be monitored in the next years.   
                                          
1 http://www.vyzkum.cz/FrontClanek.aspx?idsekce=8304  
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The existing numerous support measures need to be evaluated and streamlined in the 
next funding period. Policy measures supporting horizontal mobility such as traineeships 
or integration in the organization of industry-oriented PhD programmes are however not 
yet in place. Equity financial instruments for projects of commercialization of know-how 
in the research organizations (Proof-of-concept programme) is foreseen in the new 
Operational Programme  Enterprise and Innovation for Competitiveness (OP EIC) under 
the National innovation fund (NIF). 
Challenge 4 Increasing the innovativeness of domestic companies 
Description 
The Czech Republic is characterized by the high employment in medium-high 
manufacturing although without major changes since 2008 (11.2% in 2014 compared to 
5.7% in EU-28 and similar to Slovakia and Germany). About one quarter of Czech value 
added comes from manufacturing industry and this sector accounts for two-thirds of 
Business Expenditure on R&D (BERD).  
Still, the majority of BERD concentrates downstream with a predominance of 
experimental development rather than research and is dominated by a few large foreign 
affiliates. Foreign affiliates accounted for 55% of all business expenditure on R&D in 
2013. This results in a dual economy with R&D intensive multinational companies 
utilizing imported intermediate outputs and non-innovative and not integrated into the 
global value chains domestic companies (OECD 2014). This is evidenced by the very low 
share of SMEs introducing marketing/organisational innovations and process/product 
innovation (25th and 19th in the IUS ranking). Although the Czech Republic fares poorly 
in the use of venture capital in the IUS, its position should improve given the increased 
activity of risk investment in the country (EVCA 2014). 
Policy response 
TA CR has been established in 2009 as the dominant supporter of applied research and 
innovation and launched a portfolio of new programmes (most prominently ALFA, 
Competence Centres and the forthcoming EPSILON) but none of its programmes are 
specifically devoted to supporting innovation in SMEs. At the same time, the OP EI 
(2007-2013) funded programmes run directly by the Ministry of Trade and Industry 
supported knowledge transfer in SMEs (Innovation and Development programmes), 
while the Cooperation programme financed the establishment of technology platforms 
and clusters. 
In 2014, the Czech government has extended the existing tax credits to external R&D 
services, i.e. contractual research purchased from research organizations. This change 
was aimed at stimulating industry-academia collaborations but can also stimulate 
innovativeness of SMEs which lack human resources and infrastructure in-house. The 
SMEs are also the major beneficiaries of the existing tax incentives for R&D. 
New strategy of the Investment and Business Development Agency Czech Invest from 
2011 encourages the internationalization of Czech firms by facilitating global links 
through its Foreign Cooperation Programme and Gesher/Most programme (designed to 
support the participation of Czech companies of all sizes involved in R&D in cooperation 
with their partner companies in Israel). The internationalisation of SMEs is also one of 
the objectives of the new RIS3 strategy.  
CzechInvest provides specialized services to entrepreneurs via the projects: 
CzechAccelarator targeted on internationalization of Czech innovative companies and 
CzechEkoSystem focusing on couching young entrepreneurs.  
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Assessment 
CzechInvest has managed successfully to integrate management of the EU Structural 
Funds with FDI and innovation programmes but the creation of the new Agency for 
Entrepreneurship and Innovation (that will be created by splitting of the roles of 
CzechInvest) may have an impact on the coordination of those policies. Most of the TA 
CR funding programmes have been launched only recently and could not yet yield 
results. Still, the current policy mix is dominated by grant funding with limited efforts 
devoted to support venture capital or business angels and revolving funds. However, the 
new programming period foresees a larger portfolio of funding measures that will have 
to be designed with the lessons learned from the failure of the take up of revolving 
measures in the 2007-2013 programme. 
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1. Overview of the R&I system 
The Czech Republic is a medium size Central European country with an area of 78.9 
thousands square kilometres and population of 10.5 million people, accounting for, 
respectively, 1.8% and 2.1% of the EU28 total. In 2014, gross domestic product (GDP) 
per capita in purchasing power standards reached €23,200, 85% of the EU28 average. 
In 2012 and 2013, the economy plunged into a recession with GDP declining by 0.9% 
and 0.5%, respectively, however, in 2014 the GDP grew by 2.0% and in 2015 the 
recovery is gaining further momentum with annual GDP growth rate well above the EU28 
average (Eurostat, 2015). 
The macroeconomic situation is relatively favourable. Unemployment rate is well below 
the EU28 average and slightly decreasing from 7.0% in 2012 to 6.1% in 2014. Budget 
deficit as % of GDP halved from 3.9% in 2012 to 2.0% in 2014 and remained safely 
below the 3% threshold for two consecutive years, which is expected to last in the near 
future. Government debt as % of GDP oscillated in the narrow range of 42% to 45% 
over 2012-2014, thus not representing a major concern for macroeconomic stability.  
Despite the recession, gross domestic expenditure on R&D (GERD) significantly 
increased both in nominal terms and as % of GDP from 1.79% in 2012, to 1.91% in 
2013 and to 2.00% in 2014, hence closing the gap vis-à-vis the EU28 average. The 
share of manufacturing in value added was 37.9% in 2014, which indicates that the 
economy is one of the most industrialized in the EU28. A relatively large share of 
employment is concentrated in the high and medium-high manufacturing sectors, 
particularly automotive, mechanical and electrical engineering, while employment in 
knowledge intensive services is on the rise. However, indigenous innovation capabilities 
remain modest and there is a lingering technology gap between domestically and foreign 
owned firms. 
The Innovation Union Scoreboard 2015 (European Commission, 2015a) classified the 
Czech Republic among the “moderate innovators”, which maintain the overall innovative 
performance slightly below the EU28 average. Nevertheless, the Czech Republic moved 
up to the 2nd place in the moderate innovators category just short of Estonia but already 
ahead of Italy, Spain, Portugal and Greece. The main strengths are in upper secondary 
education, R&D expenditure in the public sector, international scientific co-publications 
and exports of medium and high-tech products. The weak areas are concentrated in top 
scientific publications, internationalization of public research sector, public-private 
scientific co-publications, access to venture capital and the output of applied research 
with regards to the usage of intellectual asset protection and licensing revenues.  
The mid-term update of the RDI policy 2009-2015 (CRDI, 2013a) and the new National 
Policy of RDI of the Czech Republic 2016 – 2020 (CRDI, 2016) reconfirmed the 
commitment to meet the 2020 national target of 1% of public spending on R&D per GDP. 
In 2014, public sector R&D funding, if combined from national and foreign sources, 
reached 0.97% of GDP, hence the national 2020 goal has been already met (Eurostat, 
2015). However, this is to a large extent due to the construction of several major EU-
funded projects of research infrastructure. It remains to be seen whether this level of 
public R&D funding will be sustained after these investments are finished. 
After a period of political instability and early parliamentary elections, a centre-left 
majority government has been formed at the beginning 2014. Pavel Bělobrádek, leader 
of the junior coalition partner the Christian Democratic Union – Czechoslovak People’s 
Party, has been appointed the Deputy Prime Minister for the Science, Research and 
Innovation, a newly created position in the RDI governance system, and the Chairman of 
the CRDI. A new Section for Science, Research and Innovations has been formed at the 
Office of the Government, which provides administrative support to the CRDI. A new RDI 
law is under preparation, which considers forming a separate Ministry for Research and 
Development, thus fundamentally reforming governance of the national RDI system. 
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Table 1 Main R&I indicators 2012-2014 
Indicator 2012 2013 2014 EU -28 
GDP per capita 15,300 14,900 14,700 27,400 
GDP growth rate -0.9 -0.5 2.0 1.4 
Budget deficit as % of 
GDP 
-4.0 -1.3 -1.9 -3.0 
Government debt as % 
of GDP 
44.7 45.2 42.7 86.8 
Unemployment rate as 
% of the labour force 
7.0 7.0 6.1 10.2 
GERD in €m 2,877 2,997 3,091 283,009 
GERD as % of the GDP 1.79 1.91 2.00 2.03 
GERD (EUR per capita) 273.9 285.0 294.0 558.4 
Employment in high- 
and medium-high-
technology 
manufacturing sectors 
as % of total 
employment  
10.5 10.8 10.9 5.7 
Employment in 
knowledge-intensive 
services as  
% of total employment  
32.0 32.8 32.2 39.8 
Turnover from 
innovation as % of 
total turnover  
18.7 15.3 13.4 11.9 
Value added of 
manufacturing as % of 
total value added 
36.6 37.4 37.9 26.2 
Value added of high 
tech manufacturing as 
% of total value added 
1.4 2.0 2.2 2.5 
Source: Eurostat (2015) 
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1.1 Structure of the national research and innovation system and 
its governance  
1.1.1 Main features of the R&I system 
RDI policy making is fairly centralized. Regional authorities, the self-governing regions at 
the NUTS3 level, do not have any legally binding responsibilities in this respect. At the 
regional level, the role of RDI policy is limited to the implementation of national 
programmes and the implementation of regional development policies. Nonetheless, the 
law does not prevent the regional authorities from launching their own RDI policy 
initiatives, though only a very few have done so, for example, by launching innovation 
voucher programmes. Nevertheless, this is changing, at least in some regions, in the 
context of the RIS3 strategies implementation. 
The private part of R&D system is characterized by openness that is one of the highest in 
the EU28. In 2014, the business sector financed 56.0% of R&D, of which roughly two-
thirds were funded from domestic sources and one third was obtained from abroad. 
Foreign public sources, predominantly the EU Structural Funds, accounted for as much 
as 32.1% of public R&D funding and recorded a major increase during the previous 
programming period. Since 2007 more than half of BERD is performed by foreign 
affiliates, a bulk of which is concentrated in R&D facilities of major multinational 
corporations. Both the HEIs and PROs play a major role in the public R&D sector. In 
2014, HEIs performed 25.5% and the PROs 18.0% of R&D. 
1.1.2 Governance 
In 2008, the Reform of the Research, Development and Innovation (RDI) system was 
launched. The reform profoundly changed the governance of RDI policy. Competences of 
particular governmental bodies are given by the Act No. 130/2002 Coll. on the Support 
of Research and Development from Public Funds and by the Reform amendment Act. no 
211/2009 Coll. The main players in RDI policy making are as follows: 
Deputy Prime Minister for the Science, Research and Innovation is a member of the 
government responsible for RDI policy supported by the Section for Science, Research 
and Innovations (SRI) at the Office of the Government. 
Council for Research, Development and Innovation (CRDI) is an advisory government 
body for RDI policy with 17 members chaired by the Deputy Prime Minister for the 
Science, Research and Innovation. At the political level, the CRDI plays the main 
strategic and coordinating role.  
Ministry of Education, Youth and Sports (MEYS) is the central administrative authority for 
R&D programmes in the public sector, particularly institutional funding for public 
universities, and for promoting international research collaboration. 
Ministry of Industry and Trade (MIT) administers policies in the domain of business RDI. 
Technology Agency of the Czech Republic (TA CR) provides competitive funding for 
applied research, experimental development and innovation. 
Czech Science Foundation (GA CR) provides funding for competitive grants in basic 
research. 
Czech Academy of Sciences (CAS) is a major funding provider and as the whole the 
single most important research performer. 
Council of Higher Education Institutions (CHEI) and Czech Rectors Conference (CRC) 
coordinate and represent higher education institutions. 
Association of Research Organizations (AVO) represents about 80 private research 
institutes specialized in applied research. 
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Association of Innovative Entrepreneurship (AIE) consists of 30 organizations 
representing about 84,000 self-employed persons and 1,100 corporations. 
CRDI proposes to the government multi-annual RDI budget plan, which consists of a 
proposal for national public RDI expenditure in the following year and an outlook over 
two additional years. Nevertheless, the outlook is frequently subject to changes in the 
next budgetary cycle, hence the multi-annual budgeting framework does not ensure 
predictable policy. So far a macroeconomic model has not been used to assess the RDI 
impact on economic growth and there are no plans to create one. 
Methodology of Evaluation of Research Organizations and Evaluation of Finished 
Programmes (valid for years 2013 - 2015), so-called Metodika 2013 (CRDI, 2013b), 
outlines the official guidelines for evaluation of public R&D support. Monitoring system is 
fairly advanced and effective. Research and Development and Innovation Information 
System of the Czech Republic (IS VaVaI) provides open access to regular, detailed and 
complete data about publicly funded support measures, projects and their outputs. Yet 
the data is underutilized for evaluation purposes. The evaluation methodology is reduced 
to descriptive tabulations of data on R&I inputs and outputs that does not provide 
strategic intelligence for programme development and policy making. Ex-ante, ongoing, 
ex-post evaluations and impact analyses that provide accurate and comparable 
information on the programmes according to international standards are not regularly 
conducted. International benchmarking of research institutions is lacking.  
1.1.3 Research performers 
At the heart of the public research sector is (i) the Czech Academy of Sciences  (CAS), 
consisting of 54 formally independent public research institutes, and (ii) 26 public, 2 
state and 44 private HEIs. Unlike in Western Europe, a large part of research activities 
are under the umbrella of the CAS, the primary mission of which is to conduct basic 
research, while the higher education sector has been traditionally less research-oriented 
and more focused on teaching. Nevertheless, this has been changing in recent years, as 
the CAS tends to get more involved in applied research and the higher education sector 
significantly expands its research activities. 
The private research sector consists of about 2,300 actors that perform R&D activities, of 
which about 25% are foreign affiliates and 80% are small and medium size enterprises. 
The main R&D performing sectors are the automotive, machinery, electronics and 
information and communication industries with about 50% share in both R&D 
employment and expenditure, respectively (CZSO, 2015a). The largest single private 
R&D performer is well-known to be the carmaker Škoda Auto, a part of the Volkswagen 
Group, which maintains a large research facility and its own private university. Other 
major business R&D performers include, for example, ABB, ČEZ, Bosh, FEI, Honeywell, 
Škoda Transportation, Visteon-Autopal and Zentiva, most of which are also foreign 
affiliates (Kejhová 2015). 
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2. Recent Developments in Research and Innovation Policy and 
systems 
2.1 National R&I strategy 
The National RDI Policy of the Czech Republic 2009–2015 (CRDI, 2009) is the central 
policy document, which has been developed to facilitate the implementation of the 
Reform of the RDI system in the Czech Republic (CRDI, 2008a). More recently, the 
Update of the National Research, Development and Innovation Policy 2009-2015 with an 
outlook to 2020 (CRDI, 2013a) assessed the progress achieved so far in implementing 
the RDI reform. The main aim of the update is to provide impetus for improving 
conditions for innovation, knowledge transfer, diffusion of frontier technologies and 
development of human resources as well as to re-align the reform agenda with the 
revised government medium-term budgetary plans in public R&D spending. 
New R&D programmes are supposed to follow the updated National Priorities of Oriented 
Research, Experimental Development and Innovation (CRDI, 2012) that have been 
summarized under six long-term thematic focus areas: i) Competitive knowledge-based 
economy; ii) Sustainable energy and material resources; iii) Environment for quality life; 
iv) Social and cultural challenges, v) Healthy population and vi) Safe society. The 
priorities are designed to reflect major societal challenges, including those outlined at 
the EU level, and needs of the society as concrete goals solvable through RDI in 
available capacities and are set for the time horizon until 2030. The new priorities should 
be taken into account in the multi-annual R&D budget plans and respected in designing 
public RDI support, including prospectively in allocation of institutional funding. The 
updated National Priorities will be extended by priorities of applied research, work on 
which will start in 2016 and are supposed to be finalized during 2017. 
The National RIS Strategy identifies eight key enabling technologies: i) Advanced 
materials; ii) Nanotechnology; iii) Micro- and nano-electronics; iv) Advanced production 
technologies; v) Photonics; vi) Industrial biotechnology; vii) Knowledge for digital 
economy, cultural and creative industries; viii) Social science knowledge base for non-
technical innovation, which are broadly in line with the long-term thematic priorities, and 
there are four national S3 platforms: i) Engineering; ii) Information and 
telecommunication services and software; iii) Transport equipment; and iv) 
Pharmaceuticals and life technologies (MEYS, 2014).  
The Government adopted a comprehensive long-term Strategy of International 
Competitiveness in 2011 (MIT, 2011a), which addressed framework conditions affecting 
innovation performance in a broad sense. The core of the competitiveness strategy 
called “3i” deals with institutions, infrastructure and innovation; the three pillars that are 
indicated as the main weaknesses of the current system. In parallel, the National 
Innovation Strategy (MIT, 2011b) that was produced jointly by the MEYS and the MIT 
develops in more comprehensive way the innovation pillar. The strategy outlines a long 
list of concrete goals for innovation policy summarized under four main priority axes: i) 
Improving conditions for excellent research; ii) Developing cooperation for transfer of 
knowledge between business and academia; iii) Promoting innovative entrepreneurship; 
iv) Skilled human resources for innovation. 
2.2 R&I policy initiatives 
During 2015, Pavel Bělobrádek, the Deputy Prime Minister for the Science, Research and 
Innovation, has formed the Section for Science, Research and Innovations (SRI) within 
the Office of the Government, which may form the basis of a separate office and 
ultimately even a full-fledged ministry. The purpose of the SRI is to coordinate the R&I 
system and integrate R&I policies, including the preparation of the national R&D budget, 
setting up of funding rules, supporting of research excellence, deepening of international 
cooperation and management of RIS3 Strategy.   
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In November 2015, The CRDI approved a proposal of National RDI Policy of the Czech 
Republic 2016–2020 (later approved by the government in Feburary 2016). The main 
priorities are to i) streamline governance of the R&I system, including clearer division of 
competences, using participatory governance in policy design and improving cooperation 
between the actors; ii) implement a new evaluation framework of research 
organizations, which provides strategic intelligence for governing of the system, and 
increase stability, predictability and effectiveness of the system of institutional funding; 
iii) develop a state-of-the-art base for applied research, stimulate transformation of the 
public research sector to more applied orientation and focus the support framework on 
addressing strategic challenges and user needs; and iv) boost R&I capabilities in the 
business sector, including streghtening technology transfer from the public sector and 
public-private cooperation and particularly promoting the sector of domestic innovative 
SMEs. The proposal has been distributed for consultations to the ministries and 
stakeholders.  
The SRI is working on a new law on the support of research, development and 
innovation, which should replace the Act No. 130/2002 Coll. on the Support of Research 
and Development from Public Funds, and may fundamentally reform governance of the 
R&I system. According to a Communication on this new act, approved at the 307th 
meeting of the CRDI in September 2015, the preferred solution recommends the 
inception of a new Ministry for Research and Development, which takes over executive 
responsibilities from the CRDI and MEYS in the R&D domain, under the umbrella of which 
will be moved GA CR and TA CR, and which thus assumes the role of the central R&D 
policy actor. Nevertheless the MIT is supposed to retain responsibilities for policies with 
regards to business R&D and innovation. Hence, the recommended solution involves the 
separation of competences for R&D and innovation policies in two ministries. It should be 
mentioned that these changes are still a matter of political debates. If the new law is 
submitted to the government and approved by the parliament in line with the schedule, 
it may become effective at the earliest from January 2017.  
A new advisory body, the Council for Competitiveness and Economic Growth (CCEG), has 
been formed under the Office of the Government. The CCEG is chaired by Pavel 
Bělobrádek, Deputy Prime Minister of Science, Research and Innovations, the deputy 
chairmen are Jan Mládek, the head of MIT, and Kateřina Valachová, the head of MEYS. 
The Council provides advice on in decision-making on conceptual issues concerning 
competitiveness and economic growth including new sectors of cultural and creative 
industries and digital economy, and contributes to achieving effective interrelation and 
coordination of government departments and strategies. The new advisory body was 
formed from the original Council for Competitiveness and Information Society that 
divided into the CCEG and the Government Council for Information Society with the aim 
of their more efficient management. 
Government resolution No. 351 from May 13th 2015 assigns Pavel Bělobrádek, the 
Deputy Prime Minister for the Science, Research and Innovation, jointly with the 
providers of project funding the task to produce and submit to the Government a 
document that delineates generally binding rules for the preparation and evaluation of 
R&I support programmes until the end of 2016. The new rules should follow basic 
principles outlined in an attachment to this resolution which stipulates that ex-ante, 
ongoing, ex-post and impact evaluations should be conducted according to the 
international evaluation standards. A number of strategic documents, e.i. CRDI (2009), 
CRDI (2013a), MIT (2011b) and Arnold (2011), emphasized the need for a major 
overhaul of the methodology of programmes evaluation, however, with a little effect on 
the evaluation practice so far. Hence, this resolution provides yet another imperative. 
Much depends on whether appropriate resources are devoted to production and 
implementation of the new rules.  
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Since 2012, TA CR has started to fund a portfolio of new programmes: i) ALFA supports 
applied research and experimental development and stimulates public-private R&D 
cooperation with a budget of about €290m over 2011-2016; ii) BETA is a programme of 
public procurement in research, experimental development and innovation for the needs 
of public administration bodies with a budget of €25m over 2012-2016; iii) OMEGA 
supports applied social science research and experimental development with a budget of 
€12m over 2012-2017; iv) Competence Centres supports projects of RDI centres in 
progressive fields that involve long-term public-private collaboration with a budget of 
about €240m over 2012-2019; v) GAMA funds the verification of R&D results in terms of 
their practical application and their commercial use with a budget of €69m over 2014-
2019; vi) DELTA provides grants for joint international projects with third countries with 
a budget of €30m over 2014-2019; and vii) EPSILON, a follow-up on ALFA, is aimed at 
supporting applied research and experimental development with a high potential for 
rapid application in innovations in three priority areas of competitive knowledge-based 
economy, sustainability of energy and material resources and environment for quality of 
life with a budget allocation of €373m over 2015-2025.  
As the result of the implementation of the Reform of the RDI System, the number of 
R&D budget providers has been halved to 11 in the budget period 2013-2015. The 
responsibility for administrating national public support for competitive funding of 
applied research, experimental development and innovation was supposed to move from 
ministries and other state institutions under the umbrella of the TA CR. However, this 
has been done only partly, as in 2015 the MIT got approved programme TRIO for 
support of business R&I and public-private research collaboration in key enabling 
technologies with a budget of €134m over 2016-2021, which partly overlaps with the 
purpose of the TA CR’s program EPSILON. Hence, national support for business R&I 
becomes fragmented into two programmes providing direct subsidies but under different 
funding providers. In addition, the MEYS and MIT continue to administer large 
Operational Programmes (OP) of the EU Structural Funds dealing with R&D and 
innovation, which require national public co-financing.  
In 2014, the government approved new OP dealing with RDI that are going to be funded 
from the European Structural and Investment Funds (ESIF) during the programming 
period 2014-2020. The OP Enterprise and Innovation for Competitiveness (OP EIC) 
under the MIT with the EU contribution of €4.32b (a total budget allocation of €7.91b) is 
designed to support the development of a competitive and sustainable knowledge and 
innovation—based economy. The OP Research, Development and Education (OP RDE) 
administered by the MEYS with the EU contribution of €2.78b (a total budget allocation 
of €3.4b) is aimed to support the transition to economy based on education, motivated 
and creative labour force, high-quality research results and their implementation in 
practice. The Operational Programme Prague – Growth Pole of the Czech Republic (OP 
PGP) administered by the Prague City Hall with the EU contribution of €0.2b (a total 
budget allocation of €0.4b) includes one priority axis directly relevant to RDI on 
“Strengthening research, technological development and innovation” that is aimed at 
promoting public-private cooperation and the establishment and development of 
knowledge-intensive companies. In 2015, these ESIFs were approved by the European 
Commission. 
New research centres and infrastructure projects financed by the OP RDI, through the 
Priority Axes 1 and 2 that are going to have a profound impact of the whole R&D system 
are under construction and gradually opening (MEYS, 2013). Six large projects with a 
total amount of subsidy of €835m (85% funded by the ERDF) were approved for funding 
in regions outside of the capital city of Prague in 2010: i) ELI - Extreme Light 
Infrastructure (€271m); ii) BIOCEV - Biotechnology and Biomedicine Research Centre 
(€92m); iii) CEITEC - Central European Institute of Technology (€209m); iv) Centrum 
excellence IT4Innovations (€72m); v) ICRC - International Clinical Research Center 
(€94m); and vi) SUSEN - Udrzitelna energetika (€97m). National programs sustainability 
I and II have been established to fund launching of the new facilities until 2020.   
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In addition, CIIRC - Czech Institute of Informatics, Robotics and Cybernetics (€54m) 
located in Prague was approved for funding (although not through the OP RDI) in 2013.  
MIT has established a new Agency for Entrepreneurship and Innovation (API). The API is 
a spinn-off from the CzechInvest investment and business development agency, from 
which around 130 employees has been transferred to the new organisation. The primary 
responsibility of API is to administer the drawdown of money from the OP EIC. The 
CzechInvest agency has previously been responsible for the drawdown of money from 
the European funds under the MIT umbrella. The main reason for this move is the 
requirement of the European Commission that all intermediary bodies servicing 
operational programmes are subject to the Civil Service Act or similar legislation. The 
rest of Czechinvest continues to operate as previously.  
Overall, these policy measures follow the National RDI Policy 2009-2015 and its mid-
term update from 2013; hence in a broad sense they jointly form a coherent and 
integrated framework for reforming the RDI system that is in line with the EU priorities 
and increasingly aimed at promoting excellence in research and fostering innovation. 
However, the degree of implementation of the reform agenda is highly uneven and often 
falls short of expectations. Stakeholders are fragmented into adversary interest groups, 
along the dividing lines of industry, university and government sectors, rather than 
working in concert. Opportunities for joint programming are seldom exploited, cross-
border cooperation remains rare and the leverage effect of EU funding largely depends 
on how the challenge of integrating the new research centres and infrastructures is 
tackled. New long-term priorities of oriented RDI announced in 2012 that are largely in 
line with the grand challenges of Horizon 2020 and the National RIS Strategy released at 
the end of 2014 are increasingly accommodated in the design of new programmes of 
targeted support.  
2.2.1 Evaluations, consultations, foresight exercises 
Metodika 2013 provides the official guidelines for evaluation of public R&I support for 
both research organizations and programmes (CRDI, 2013b). However, the evaluation 
methodology is essentially limited to monitoring and accounting of data collected in the 
IS VaVaI, predominantly on research outputs, but does not provide strategic intelligence 
in terms of assessing the quality of research organizations, policy interventions, 
counterfactual analysis, impact evaluation and international benchmarking that can be 
taken on board in policy, management of the research organizations and programme 
development. Methodology for evaluation of R&I programmes is outlined in a mere two 
pages and largely reduced to ex-post reporting of inputs and immediate outputs; ex-
ante, ongoing, and ex-post impact evaluations are not conducted according to 
international standards. The evaluation system is lacking financial, data and human 
resources for delivering evidence-based recommendations for policy making. For a lack 
of better solution in hand, the validity of Metodika 2013 has been extended by one year 
until the end of 2016. 
The results of an individual national project, funded from the OP EC, on “Effective 
System of Research Financing, Development and Innovation” (IPN Metodika) aimed at 
proposing a new system of research financing, development and innovation, were 
presented at a final conference in October 2015. The main outcomes are a proposal for 
methodology of evaluation of research organizations based on informed peer review, 
including a pilot implementation thereof, and performance-based principles for the 
allocation of institutional funding (Arnold and Mahieu, 2015).   
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Other outputs include proposals for upgrading of the IS VaVaI, evaluation methodology 
for research infrastructures (IPN Metodika, 2014) and general guidelines for evaluation 
of R&I support programmes (Srholec, 2015)2.  
The Analysis of the State of Research, Development and Innovation in the Czech 
Republic and a Comparison with the Situation Abroad in 2014, an annual overview of the 
R&I system, has been presented to the government in September 2015 (Office of the 
Government of the Czech Republic, 2015a). After the establishment of the SRI, which is 
responsible for its production, the analysis has been fundamentally revised and can be 
considered as an early attempt for developing system-level evaluation. The analysis 
highlights the improving quality of science infrastructure, international science 
cooperation and human resources in research but points to lagging behind in applied 
research, public-private collaboration and technology transfer as well as to the 
fragmentation of the R&I governance system. The recommendations include 
strengthening the focus of R&I policy on priority areas, deepening support of public-
private linkages that stimulate R&I efforts in the business sector and a reform of the R&I 
governance. 
Innovation capacity 2014+ (INKA) project, administered by TA CR and implemented by a 
consortium of Berman Group, South Moravia Innovation Centre and Technopolis, maps 
the national innovation landscape. The aim of the project is to develop a methodology 
for regular screening of the national innovation potential in order for TA CR to identify 
areas in which the economy is more innovative and competitive. The project should help 
TA CR to determine the extent to which there is demand for research results in the 
business sector, what kind of research leading to innovation should be performed and 
which instrument for state support of research are suitable. The project includes primary 
data collection through in-depth interviews of about three hundred innovative 
enterprises. Results of the pilot implementation of the proposed methodology should be 
released in the first half of 2016. 
During 2014 and 2015, TA CR organised a project on “Increasing  the effectiveness of TA 
CR in RDI intervention and improving RDI public administration capacities” funded from 
the OP Human Resources and Employment (OP HRE) under the Ministry of Labour and 
Social Affairs (MoLSA). The main objective of which is to improve the provision of project 
funding for applied research and innovation and strengthen professional capacity in this 
field; partial objectives include i) setting of an analytical framework to grasp the results 
and impacts of RDI; ii) deepen the involvement of experts within the RDI support 
system; iii) streamlining of the available advisory services; iv) the development of 
methods for innovative public procurement; and v) raising awareness and educating the 
state bureaucracy in these matters. Pilot testing of the proposed measures, which 
involved among others the cooperation of TA CR, EGAP,the CzechTrade and CzechInvest 
agencies, were also conducted in the project.  
MEYS conducted an evaluation of the sustainability of research centres supported from 
the OP RDI (MEYS 2015), which includes detailed consideration of their financing 
requirements, analysis of their funding prospects and risk assessment. The evaluation 
methodology involved desk research as well as site visits. The main conclusion is that 
there is an urgent need to put in place a complex national strategy for safeguarding the 
sustainability of the new research centres, because a number of them is already in 
operation and their sustainability is being under pressure It has been recommended that 
the national strategy cuts across ministries and should clearly address the funding 
requirements. 
  
                                          
2 The author was commissioned by the IPN Metodika project to prepare this document over the 
period from November 2014 to Novermber 2015. 
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Using a methodology for evaluating large RDI infrastructures prepared in the IPN 
Metodika project (IPN Metodika, 2014), a comprehensive two-stage assessment of all 
existing and planned projects of large R&D infrastructures was carried out by the MEYS 
in the second half of 2014. The evaluation was based on information submitted by 
research organisations, which registered their projects on a voluntary basis. In total, 119 
projects have been assessed and out of that 58 successfully passed the evaluation. The 
outcome of the evaluation was used in the update of National Roadmap for Large 
Research, Experimental Development and Innovation Infrastructures (MEYS, 2015a). 
The Update of the National Research, Development and Innovation Policy 2009-2015 
with an outlook to 2020 has been approved by the government resolution No. 294 on 
24th April 2013 (CRDI, 2013a). The update provides a comprehensive evaluation of the 
progress in implementing the RDI policy. The update revolves around four priority areas: 
i) Supply of high-quality human resources; ii) Enhancing the framework for transfer and 
utilization of knowledge; iii) Boosting the innovative capacity in the business sectors and 
iv) Improving strategic management of the system. The update emphasized the need to 
improve conditions for innovation, knowledge transfer and diffusion of frontier 
technologies. Another purpose of the update is to re-align the reform agenda with the 
government medium-term budgetary plans in public R&D spending, which have been 
significantly downsized in the aftermath of the economic crisis.  
In August 2015, Office of the Government commissioned a mid-term assessment of the 
National Policy 2009-2015. This mid-term assessment conducted by study team led by 
the Technology Centre of the ASCR involved indicator-based evaluation of the strategic 
goals set by the National Policy as well as qualitative assessment of individual policy 
measures. Results of the mid-term assessment were used in the preparation of the new 
National Policy 2016-2020 (CRDI, 2016). 
2.3 European Semester 2014 and 2015 
The national 2020 target is to reach 1% of public R&D expenditure per GDP. Already in 
2012 government sector R&D funding obtained from national sources reached 0.66% of 
GDP, whereas public R&D funding from abroad, primarily from the EU Structural Funds, 
amounted to 0.29% of GDP, which in total is 0.95% of GDP. In 2013 and 2014 the total 
figure of publicly funded R&D spending further edged up to 0.97% of GDP; primarily due 
to a small increase of the foreign component to 0.31% of GDP (Eurostat, 2015). Hence, 
the national 2020 goal has been almost met, if the foreign public sources are included. 
However, this is to a large extent due to a spike of EU funding for the construction of 
several major projects of research infrastructure. It remains to be seen whether the 
increased level of public R&D funding will be sustained after the investment phase of 
these large-scale investment projects fizzles out.  
Country-specific recommendations for the Czech Republic in 2014 (European 
Commission 2014b) emphasize that deeper changes need to be introduced in the 
funding of research institutions that provide right incentives to strive for excellence, 
address societal challenges and promote public-private cooperation and thus that there 
is a need to accelerate work on the new methodology for the evaluation of research 
organizations and performance-based allocation of institutional funding. The 2015 
European Semester Country Report (European Commission, 2015c) concluded that there 
has been only limited progress in addressing the 2014 country-specific recommendation 
on a new methodology for evaluating research and allocating research funding.  
The National Reform Programmes 2014 and 2015 – in line with European Commission 
(2014b and 2015c) - stipulate that a new system of evaluation of research organisations 
and allocation of institutional funding is put in place (Office of the Government of the 
Czech Republic 2014a and 2015b). The IPN Metodika project aimed to produce the new 
methodology and funding rules by mid-2015. After several rounds of consultations with 
the stakeholders, the final results were published in May 2015 (Arnold and Mahieu, 
2015).   
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Pilot testing of the new methodology has been conducted and an implementation plan 
has been produced. Hence, after several years of a stalemate there has been a new 
important development, which has a potential to bring international best practices of 
informed peer review into the core of the evaluation methodology. The proposed 
changes in the evaluation framework are taken into account in preparation of the new 
law on the support of research, development and innovation. Nevertheless, no clear 
roadmap for implementation of the new methodology has been approved by the 
government so far and it is expected that funding decisions could be based on results of 
the new methodology at the earliest in 2018. 
Moreover, the National Reform Programme 2014 (Office of the Government of the Czech 
Republic, 2014a) recommends designing a new methodology of evaluation of targeted 
RDI support programmes, which includes ex-ante, interim and ex-post stages, and which 
involves the assessment of the intervention logic and evaluation of their effectiveness, 
results and impacts. In 2014, a working group consisting of the main providers of 
targeted funding started to work out the solution under the auspice of the CRDI, the 
results of which is a memorandum drafted by the SRI and approved by the leadership of 
CRDI in spring 2015 on “Basic principles of the preparation and evaluation of 
programmes and groups of grant projects for research, development and innovation 
(Office of the Government of the Czech Republic, 2015c). Government Resolution No. 
351 from 13 May 2015 calls for the main stakeholders to produce on the base of these 
principles and submit to the government until the end of 2016 generally binding rules for 
preparation and evaluation of RDI programmes. In the meantime, the IPN Metodika 
project proposed general guidelines for evaluation of RDI programmes and systemic 
changes needed for their implementation (Srholec, 2015), which further elaborate on the 
basic principles. Hence, this recommendation has not been fulfilled so far, but there are 
two general documents that address this issues and a clear imperative by the 
government to achieve significant progress along these lines in a near future. 
Finally, as required by the National Reform Programmes 2014 and 2015 (Office of the 
Government of the Czech Republic, 2014a and 2015b), the government prepared with 
the help of IPN Metodika a project of a methodology for evaluating large RDI 
infrastructures that is built on the principles of an informed international peer-review 
(IPN Metodika, 2014).In fact, the methodology has been already implemented in a 
comprehensive evaluation of research infrastructures that has been conducted by MEYS 
in the second half of 2014.  
2.4 National and Regional Research and Innovation Strategies 
on Smart Specialisation 
Czech regional authorities, consisting of 14 self-governing regions at the NUTS3 level, do 
not have any legally binding responsibilities in RDI policy. Yet the law does not prevent 
them from launching own RDI initiatives, which is, however, difficult given their 
restricted budgets. So far their main role has been in catalysing the EU Structural Funds 
projects, primarily those funded from the OP RDI. The South Moravian region is the main 
exception representing the national role-model of regional innovation policy with 
dedicated authorities, a well-functioning innovation agency and a dialogue with the 
business community; for more information see (RISJMK, 2013). Several other regions 
are attempting to emulate this model with various degrees of success, most prominently 
Prague, Moravia-Silesia, Liberec, Zlín and Hradec Králové regions, while other regions 
have either only paid a lip service or ignored the need to developing regional innovation 
policy altogether. 
MEYS accepted the responsibility for designing the RIS3 strategy and appointed the so-
called RIS3 Coordination Board in November 2012 (MEYS, 2014). Regional RIS 
managers were selected in April 2013 and the national RIS3 facilitator was assigned in 
September 2013. The regional managers were appointed and funded by the MEYS. Only 
South Moravia and the Capital City of Prague have started to work on their RIS3 
strategies in a bottom-up manner, independently of the centralized initiative.   
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It remains to be seen to which extent the top-down approach to crafting of the regional 
RIS3 strategies makes a tangible difference on the ground, especially in the regions 
where indigenous initiative and innovation policy capabilities have been very limited so 
far.  
The National RIS3 Strategy has been approved by the government and submitted to the 
European Commission in December 2014. The key enabling technologies have been 
specified as: i) Advanced materials; ii) Nanotechnology; iii) Micro- and nano-electronics; 
iv) Advanced production technologies; v) Photonics;  vi) Industrial biotechnology; vii) 
Knowledge for digital economy, cultural and creative industries; and viii) Social science 
knowledge base for non-technical innovation. Four national S3 platforms have been 
formed: i) Engineering; ii) Information and telecommunication services and software; iii) 
Transport equipment; and iv) Pharmaceuticals and life technologies; more are expected 
to be added through the entrepreneurial discovery over time. The strategy provided 
detailed consideration of financial requirements from the ESIF, particularly the OP RDE, 
the OP EIC and the OP PGP; however, there were no details on the use of national funds 
beyond the ESIF co-financing; this was left to be specified by the government annually. 
Monitoring reports are also to be published annually and evaluation is scheduled to be 
conducted every two years in line with the update of the strategy.  
In 2015, the management and implementation of the RIS3 strategy has been transferred 
under the auspice of the Deputy Prime Minister for the Science, Research and 
Innovation, hence the SRI has become responsible for its implementation.  However, the 
European Commission did not approve the submitted version of the RIS 3 strategy and 
demanded a revision, in particular the improvement of the alignment with national 
funding. As the result, an action plan on how to fulfil the ex-ante conditionality that 
includes the intermediate plan of activities of the SRI and quantification of relevant 
financial allocations in public budgets have been agreed and is being implemented. The 
RIS 3 strategy has been updated accordingly and sent for verification to the European 
Comission in the fourth quarter of 2015. After successful verification by the European 
Comission, the updated RIS3 strategy will be submitted to the government. 
So far RDI policy making has been fairly centralized. Co-ordination between the national 
and regional level innovation strategies has been very weak, if not missing altogether. 
National innovation strategy has addressed the regional aspects of innovation vaguely 
only. Drafting of the national RIS3 strategy and most importantly its implementation 
involved, at least formally, a coordinated action of the national and regional authorities 
on the topic of innovation policy; hence representing a much needed opportunity for 
establishing a nation-wide debate on this topic. Needless to say, it is pertinent that this 
dialogue is sustained beyond this particular purpose and elements of multilevel 
governance of the RDI system become gradually implemented.  
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2.5 Main policy changes in the last five years 
 
Main Changes in 2011 
Strategy of International Competitiveness addressed framework conditions 
affecting innovation performance. 
National Innovation Strategy outlined goals for innovation policy. 
TA CR starts funding projects in the first programme ALFA. 
Main changes in 2012 
National Priorities of Oriented Research, Experimental Development and 
Innovation started to guide the design of new support programmes. 
The number of R&D budget providers was halved to 11 in the multi-annual 
budget plan. 
TA CR started funding BETA, OMEGA and Competence Centres programmes. 
TIP programme of the MIT was defunded in medium-term. 
Regional governments started to implement innovation voucher programmes. 
Main changes in 2013 
Update of the National Research, Development and Innovation Policy 2009-2015 
with an outlook to 2020 re-confirmed the reform track. 
Metodika 2013 provided a medium-term modification of the formulae-base 
evaluation of research organisations and allocation of institutional funding. 
Higher education reform ended up in doldrums. 
The centre-right coalition government collapsed, early elections were held, and a 
new centre-left government was formed. 
National programs sustainability I. and the prospective National program 
sustainability II. were put in place to sustain financing of the new research 
centres and infrastructures. 
Main Changes in 2014 
National RIS Strategy was released. 
Nine out of sixteen members of the CRDI council were replaced. 
Pavel Bělobrádek was appointed the Deputy Prime Minister for the Science, 
Research and Innovation and the Chairman of the CRDI. 
MEYS signed under the IPN Mmetodika project a contract with Technopolis Group 
to design a new system of evaluation of research organisations and allocation of 
institutional funding. 
TA CR started funding the GAMA and DELTA programmes. 
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MIT shut down the project Seed Fund to launch a public-private venture capital 
fund. 
GA CR did not issue a new call for postdoc projects but started a new 
programme of junior projects. 
R&D tax credits were extended to purchase of external R&D services from 
research organisations. 
Main Changes in 2015 
The SRI section started operation at the Office of the Government. 
TA CR started funding the EPSILON programme, while MIT got approved the 
TRIO programme. 
The OP EIC, OP RDE and OP PGP started to be implemented in the new 
programming period. 
Metodika 2013 guidelines for evaluation of public R&I support were extended 
until the end of 2016, while new guidelines are expected to be put in place in the 
period 2017 onwards. 
The IPN Metodika project proposed a new methodology for evaluation of 
research organizations and principles for allocation of institutional funding as 
well as a methodology for evaluation of research infrastructures and guidelines 
for evaluation of RDI programmes. 
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3. Public and private funding of R&I and expenditure 
3.1 Introduction 
In 2014, gross domestic expenditure on R&D (GERD) amounted to €3.1b (CZK 85b) and 
increased by about 9% as compared to the previous year, driven mainly by the 
expansion of foreign business funding. GERD jumped by 71% over the period 2008-
2014, which marks a remarkable recovery. As a consequence, R&D intensity of the 
economy in terms of GERD as % of GDP increased to 2.00% in 2014, as compared to the 
lowest point of 1.24 % at the dawn of the crisis in 2008, hence noticeably approaching 
the EU28 average of 2.03% (Eurostat, 2015).  
Business enterprise expenditure on R&D (BERD) accounted for 56% (€1.73b) of the 
total, the higher education sector came second with 25% (€0.79b) closely followed by 
the public research institutions with 18% (€0.56b), while the private non-profit sector 
remained negligible accounting for less than 1% (€0.01b) in 2013. BERD as % of GDP 
reached 1.12% in 2014, which represents a significant increase compared to 0.86% in 
2011, the crisis bottom of 0.73% in 2008, and about 0.70% ten years ago, hence 
noticeably catching-up with the EU28 average of 1.30%. The national 2020 target of 1% 
public R&D intensity of GDP has been reached already, if foreign public sources are 
factored in, however, national public sources tend to grow slowly, which casts doubts 
about sustainability of the recent R&D investments growth (Eurostat, 2015). 
In 2014, the indigenous business enterprise sector financed 36% (€1.11b) of GERD,. The 
government sector funded 33% of GERD (€1.02b), most of which is split between higher 
education (48%) and public research institutions (35%). Foreign sources in total 
contributed by 30% (€0.94b) of GERD funding in 2014, more than tripling from only 9% 
in 2008, which makes the latter by far the most dynamic source. About half of the 
foreign funds came from public sources in; predominantly the EU funds, and the other 
half from private sources, thus funding of R&D in foreign affiliates through multinational 
corporations. (Eurostat, 2015 and CZSO, 2015a). 
Government budgetary appropriations or outlays for R&D (GBAORD) amounted to 
€0,97b (CZK 26.64b) and 0.63% of GDP in 2014, which represents a noticeable increase 
from €0.82b (CZK 20.49b) and 0.51% of GDP in 2008, respectively; however, the rise is 
largely due to the need to co-finance the EU Structural Funds.  As the result, GBAORD as 
% of GDP nearly eliminated the gap as compared to the EU28 average of 0.67%, despite 
major cuts in other parts of the government budget during the prolonged recession. 
GBAORD stagnated in the narrow range between 0.64% and 0.66% of GDP over 2011-
2014 and even somewhat dropped from 2013 to 2014, hence did not keep up with the 
economic recovery (Eurostat, 2015).  Nevertheless, GBAORD is earmarked to slightly 
increase to CZK 26.91bin 2015 (CRDI, 2015) and further increase to CZK 28.59b in 
2016, CZK 29.00b in 2017 and CZK 29.17b in 2018 according to the multi-annual R&D 
budget plans approved by the government (Office of the Government of the Czech 
Republic, 2015d). 
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Table 2 Basic indicators for R&D investments 
Indicator 2011 2012 2013 2014 2015 EU 28 
GERD (as % of GDP) 1.56 1.79 1.91 2.00 .. 2.03 
GERD (Euro per 
capita) 
243.4 273.9 285.0 294.0 .. 558.4 
GBAORD (€m) 1,050.6 1,039.8 1,027.9 967.3 967.3 92,828 
R&D funded by BES 
(% of GDP) 
0.59 0.65 0.72 0.72 .. 1.12 
R&D funded by GOV 
(% of GDP) 
0.65 0.66 0.66 0.66 .. 0.66 
R&D funded by HES 
(% of GDP) 
0.01 0.02 0.01 0.01 .. 0.02 
R&D funded by PNP 
(% of GDP) 
0.00. 0.00 0.00 0.00 .. 0.03 
R&D funded from 
abroad (% of GDP) 
0.31 0.46 0.52 0.61 .. 0.20 
R&D performed by 
HEIs (% of GDP) 
0.38 0.49 0.52 0.51 .. 0.47 
R&D performed by 
government sector 
(% of GDP) 
0.31 0.33 0.35 0.36 .. 0.25 
R&D performed by 
business sector (% of 
GDP) 
0.86 0.96 1.03 1.12 .. 1.30 
Source: Eurostat, 2016 
3.2 Smart fiscal consolidation 
3.2.1 Economic growth, fiscal context and public R&D3 
The Czech Republic weathered the 2008-09 economic crisis with a relatively moderate 
real GDP loss of 4.8% and only once in 2009. However, the post-crisis recovery was slow 
throughout 2010-2013. After a somewhat more solid growth in 2014 (2%) driven by 
domestic demand with particularly strongly growing investment the Czech economy has 
grown by 4.8% in 2015 driven not only by robust domestic demand (both consumption 
and investment) but also by solid public investments on the back of EU funding. The 
Commission projects real GDP growth to be around 2.3-2.7% in 2016-17 due to fading 
out of the effect of EU funding on the investments.  
                                          
3 http://ec.europa.eu/europe2020/pdf/csr2016/cr2016_czech_en.pdf 
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Before the crisis the Czech Republic had sound public finances characterized by low level 
public debt level (28% of GDP) and government deficit on a decreasing path (0.7% of 
GDP in 2007) due to fiscal discipline and strong economic growth. During 2008-09 the 
deficit reached 5.5% of GDP and public debt increased rapidly by about 10% of GDP. 
Fiscal adjustments through increases in indirect taxation and important cuts in public 
investment in the following years brought down the headline deficit to 1.3% of GDP by 
2013 and balanced the government budget in structural terms. This has worsened 
slightly to 1.9% and 0.7% of GDP deficits in headline and structural terms, respectively. 
European Commission estimates a slight improvement of the deficit to 1.6% of GDPdue 
to better than expected corporate tax collection. The headline deficit is expected to fall 
to 1.1% of GDP in 2016 and 1% of GDP in 2017 due to sharp decline in public 
investments. The debt ratio is moderate (41% of GDP) and due to fiscal discipline it is 
expected to remain so (40% of GDP) throughout 2016-2017. However, long-term 
sustainability of public finances remains an issue due to population ageing triggering 
increases in pension- and healthcare spending. 
 
 
 
 
Figure 2 Government deficit and public debt. 
Data Source: Eurostat 
 
Total GERD in the Czech Republic was €2,997m in 2013. There are three main sources of 
R&D funding: the business sector (€1,127m), the government (€1,041m), and foreign 
funding (€814m). Direct funding from the government goes to R&D in business 
enterprises (€188m), the government (€364m) and the higher education sector 
(€485m).  
 31 
 
Table 3 Key Czech Public R&D Indicators Source: Eurostat 
  2007 2009 2013 2014 
GBAORD, % of gov. exp. 1.29 1.32 1.56 1.5 
GERD, % of GDP 1.31 1.30 1.91 2 (p) 
out of which GERD to public, % of 
GDP 0.54 0.56 0.87 
0.87 (p) 
Funding from GOV to, % of GDP     
   Business 0.12 0.13 0.12 0.11 (p) 
   Public (GOV+HES) 0.46 0.49 0.54 0.55 (p) 
   Total 0.58 0.62 0.66 0.66 (p) 
EU funding, % of GDP 0.02 0.03 0.30 n.a. 
Source: Eurostat 2015, p - provisional 
3.2.2 Direct funding of R&D activities 
The sources of R&D funding according to the Frascati manual are: Government sector 
(GOV), Higher education sector (HES), Private non-profit sector (PNP) and Abroad 
(including EC). In this analysis the public sector as source of funds is given by the GOV 
part of the total intramural R&D expenditure (GERD), whereas the public sector as a 
sector of performance is the aggregation of GOV and HES. Figure 3, below shows the 
historical evolution of GERD financing in current prices in Czech Republic. 
 
Figure 3 Development of government funding of the total GERD Data source: Eurostat 
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The total R&D expenditure (GERD) in nominal terms was slightly affected by the crisis 
and only for a short period of time 2008-09 after which it started increasing again, 
slowly at the beginning and more substantially in 2011 onwards. The reasons for this 
spectacular progress after 2011 are two: the increase in the R&D funding received from 
the European Commission via Structural Funds for R&D and the increase of the business 
R&D investments which had been affected during the crisis period. The private and 
public sectors contribute almost equally to the funding of R&D throughout the period of 
this study, and sometimes even complementing each other. For example, while R&D 
investments of the private sector dropped during the crisis in 2009, public R&D 
expenditure slightly increased resulting to an almost stable total GERD. GERD in 2014 
increased due to abroad funding, both from business and the European Commission.  
3.2.2.1 Direct public funding from the government 
 
Figure 4 R&D appropriations and government funded GERD in millions of national 
currency Data source: Eurostat 
Figure 4 shows that although the total R&D appropriations (GBAORD) are lower than the 
actual public expenditures on R&D, they both follow the same trend, especially when 
expressed in nominal values. This pattern is common for the Member States that joined 
the EU after 2004 and it could be due to the Structural Funds, although it remains 
uncertain how these quantities are related. When analysed as % of GDP, the GERD 
funded by government is lower than GBOARD as from 2010. In addition, the gap 
between the total civil R&D appropriations and total GBOARD is very small, which means 
that the military R&D plays a minor role in the Czech public expenditure.  
In 2011, GBAORD and GERD funded by the government increased significantly, 
especially when expressed as % of GDP. Since then, the fluctuations were small and the 
overall trend was positive. In 2014 the GBAORD when measured in national currency, 
stagnated roughly at the same level and was subject to a slight increase in 2015. Further 
increases are foreseen for 2016-2018 period according to the multi-annual R&D budget 
plans approved by the government4. However, before the financial crisis in the reform 
agenda of 2008 the government declared plans to keep increasing public R&I funding by 
as much as 8% annually, which indicates that in reality there has been a major reduction 
of the growth of public R&I spending.   
                                          
4 Návrh výdajů státního rozpočtu České republiky na výzkum, experimentální vývoj a inovace na 
rok 2016 s výhledem na léta 2017 a 2018, http://vyzkum.cz/FrontClanek.aspx?idsekce=736349 .  
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One notices that the growth of the GERD funded by government and EC together is 
much sharper than the GERD funded by the Czech government alone, which 
demonstrates clearly the importance of the structural funds for R&D. When the same 
quantity is expressed as percentage of GDP, the increase is even sharper, due to a 
decrease in Czech GDP in 2012 (by 1%). 
3.2.2.2 Direct public funding from abroad 
Table 4 Public Funding from Abroad to the Czech R&D (in millions of national currency) 
Source from 
abroad 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 
Total 2057.27 2061.64 3632.41 4431.13 5736.32 7376.40 12335.61 18758.24 21138.70 25939.09 
BES 1391.62 1340.71 2707.24 3467.05 4431.13 5160.40 6242.42 7136.22 8563.01  NA 
EC     794.61 863.07 1152.55 1998.81 5943.04 11502.58 12407.31  NA 
GOV         67.81 77.72 56.78 10.50 0.00  NA 
HES         14.38 34.61 1.03 2.81 3.04  NA 
International 
Organizations     15.12 21.43 68.40 97.21 71.28 80.45 61.11  NA 
Total as % 
GERD 5.39 4.76 7.26 8.89 11.28 13.92 19.66 25.92 27.15 30.48 
EC as % 
GOVERD     3.55 3.86 4.74 8.49 22.70 43.22 45.88  NA 
 
Table 4 confirms the increasingly important role of the structural funds in the funding of 
R&D activities in the Czech Republic.  EC contribution increased from 3.5% of the 
publically funded GERD in 2007 to almost 46% in 2013. In general, external funding 
(category abroad) has become very important as it represented 13.9% of the total GERD 
in 2010 and over 30% in 2014. It is important to note that this is not only due to the 
increase in the structural funds but also due to the less dramatic but significant increase 
in the funding from foreign businesses. Indeed, until 2011 foreign R&D investments from 
the business sector where the major source of external funding.  
Based on data from DG REGIO, the total Structural Funds for the period 2007-2013 for 
Czech Republic amounted to 26.5 billion Euros of which 2.9 billion (i.e. 11%) is 
dedicated to 'Core' R&D activities. Unlike other Member States from Eastern Europe, 
Czech Republic's share of SF allocated to R&D is higher than the equivalent share at 
EU28 level (9.4%), which shows the importance of the R&I policy. The role of the 
Structural Funds for R&D is clearly visible and it has rapidly increased in 2011-2012. 
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Distribution of public funding  
Figure 5 shows how the government expenditure for R&D is distributed between the 
public and the private sectors. 
 
Figure 5 Government intramural expenditure by sectors of performance 
Data source: Eurostat 
 
The public sector is the main recipient of government funded GERD and was the one 
affected the most by the cuts in 2010 due to the financial crisis. Direct support from the 
government to business decreased during the 2011-14 period. However, at the same 
period the indirect support to business sector through tax incentives increased, 
compensating for this loss (see section 3.3.3 below). 
3.2.3 Indirect funding – tax incentives and foregone tax revenues 
The Czech R&D tax credit scheme was introduced in 2005 with the aim of stimulating 
private R&D expenditure. It was introduced as a deduction from the income tax in the 
amount of 100 % of expenditure on R&D in the taxable period5.   
In 2014 the tax credits were extended to external R&D services, i.e. contractual 
research, purchased from research organizations. This change was aimed at stimulating 
industry-academia collaboration.  
 
 
Figure 6 Indirect support for R&D (2005-2013) in CZKm and as % of state budget6. 
Source: Czech Statistical Office February 2016  
                                          
5
http://www.czechlegislation.com/en/586-1992-sb , 
http://portal.gov.cz/app/zakony/zakon.jsp?page=0&nr=586~2F1992&rpp=15#seznam  
6 https://www.czso.cz/csu/czso/neprima-verejna-podpora-vyzkumu-a-vyvoje-v-ceske-republice-
2014 
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Both the amount of R&D tax credits and the number of enterprises that are applying for 
the indirect support were growing till 2013. In the first year (2005) 434 of enterprises 
used the tax relief, in 2010 the number almost doubled (716), and in 2014 reached 1 
264 enterprises. The amount of the tax relief decreased slightly in 2014 (from CZ 2 
297m to CZK 263m) even though in the 2014 the tax relief allowed also for the 
deduction of the highest share of the tax credits are allocated to the automotive sector 
and more generally to the manufacturing sector. For the first time in 2013 it was used by 
the financial and insurance sector.  
Eighty six percent of firms that use the indirect R&D support have less than 250 
employees, however they receive only 30% of the total indirect funding as their 
expenditure on R&D is much lower than in large companies. For the SMEs the direct 
funding remains the major source of funding, whereas for the large companies the 
indirect funding is slightly over 60% of the total (indirect and direct) public funding for 
R&D 7.  
 
Figure 7 Direct and Indirect R&D support 
 
Figure 7 is based on national data (for the foregone tax revenues) and Eurostat (for the 
GBAORD) and it gives an idea of the evolution of the relative size of the direct and 
indirect R&D support. 
 
 
Figure 8 Direct and Indirect funding of R&D (source: OECD) 
  
                                          
7 Ibidem  
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The increase in the indirect public support to R&D can also be seen in relative terms, as 
% of GDP, in Figure 8 which is based on data from OECD. 
3.2.4 Fiscal consolidation and R&D 
The post-crisis fiscal consolidation in the Czech Republic took place practically between 
2010 and 2013 both nominally and in structural terms. Figure 10, below shows the 
scatterplot of the structural balance and GBAORD as % GDP, first panel as well as GERD 
as % GDP, second panel8: 
 
Figure 9 Fiscal consolidation and R&D Data source: AMECO, Eurostat, OECD, National 
sources 
 
While the structural deficit shrank and turned into a surplus during 2010-2013, both 
GBAORD and government financed GERD increased or at least stayed at the same levels. 
The slight decrease of GBAORD in 2014 is rather minor. Therefore, we can argue that 
post-crisis fiscal consolidation did not have a negative impact on direct public support to 
R&D. Adding indirect funding through R&D tax incentives further improves the picture. 
Also as show previously the EU funding was very important for the public funding of the 
Czech R&I system during the fiscal consolidation period. 
The post-crisis fiscal adjustment process has not come at the expense of public support 
to the Czech R&D. However it has significantly retarded the increase in the R&D budget 
foreseen in the pre-crisis period. The slower growth of direct funding was compensated 
by the use of the EU Structural Funds for R&D and the increase in the indirect support 
for R&D.  
3.3 Funding flows 
3.3.1 Research funders 
MEYS and CAS are the main providers of funding distributed within the public research 
sector. MEYS primarily provides research funding to the HEIs sector with a budget of 
€383m (CZK 10.53b) in 2014 that is earmarked to increase to €409m (CZK 11.26b) in 
2015 and to €449m (CZK 12.35b) in 2016. Institutional funding, which accounts for 
about two-thirds, is divided between the individual HEIs strictly on the base of the points 
obtained in the annual performance-based evaluation exercise following Metodika 2013 
(for more details see Section 3.4.2). Project funding is organized in a variety of 
programs, which widely differ in the underlying allocation mechanisms, however, most of 
which involve elements of peer review; again predominant recipients are the HEIs. CAS 
has its own line in the national R&I budget that consists solely of institutional funding 
with a budget of €162m (CZK 4.45b) in 2014 that is earmarked to growth to €164m 
(CZK 4.52b) in 2015 and to €175m (CZK 4.83b) in 2016.   
                                          
8 Structural balance data comes from the AMECO database the other indicators were taken from 
Eurostat and OECD. 
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The funding is distributed among 54 PROs that are members of the academy on the base 
of its own evaluation methodology based on international peer review, which is 
conducted every five years (CRDI, 2015b). 
GA CR and TA CR are formally independent agencies that provide competitive project 
funding. GA CR administers project-based funding of basic research with a budget of 
€126m (CZK 3.46b) in 2014 that is earmarked to growth steadily to €134m (CZK 3.68b) 
in 2015 and to €139m (CZK 3.83b) in 2016, the primary recipients of which are the HEIs 
and PROs; the funding is allocated using international peer review. TA CR that has been 
established in 2009 provides project-based funding for applied research, development 
and innovation through a wide portfolio of new programs with an overall budget of 
roughly €100m (nearly CZK 3.00b) over 2014-2016; the funding is allocated on the base 
of external domestic peer review and distributed to both private and public recipients, 
including their joint projects (CRDI, 2015b). 
MIT used to be the main provider of national project-based support to business RDI 
before TA CR started to take over this role and its line in the national R&I budget has 
been declining ever since from €139m (CZK 3.82b) in 2010 to the bottom of €31m (CZK 
0.85b) in 2015. Nevertheless, MIT is re-emerging as the provider of direct R&D subsidies 
to business enterprises, hence its budget is earmarked to start increasing to €41m (CZK 
1.12) in 2016 again; the funding is predominantly allocated on the base of peer review 
panels and flows predominantly to the business sector. Less significant amounts are 
channelled through five other ministries, namely the Ministry of Agriculture, Ministry of 
Culture, Ministry of Defence, Ministry of Health and Ministry of Interior with individual 
national budget lines of roughly €50m (CZK 1.3b) and less in 2014 (CRDI, 2015ab). 
In addition, MEYS and MIT coordinate the EU Structural Funds with sizeable resources 
devoted to RDI funding. In the previous programming period 2007-2013, MEYS 
administered the OP RDI and OP EC with a combined budget of about €3.8b and MIT 
administered OP EI with a total budget of of €3.0 for RDI relevant activities and the 
Prague City Hall administered the OP PC and OP PA with which innovation activities with 
only a small fraction of possible R&D financing were also supported; these OPs expired in 
2015. In the current programming period 2014-2020, MEYS coordinates the OP RDE with 
a total budget allocation of €3.4b, MIT coordinates the OP EIC with a total budget 
allocation of €7.91b and the Prague City Hall coordinates the OP PGP with a total budget 
allocation of €0.4b. The main recipients of the OP research funding from MEYS are the 
HEIs and PROs, while most of the funds channelled through MIT are directed to the 
business sector. 
Private non-for-profit funding of public research performers plays a very marginal role. 
The only source of philanthropic funding that deserves to be mentioned is the Neuron 
foundation, established in 2013 by merging with the Czech billionaire Karel Janeček 
Benevolent Fund for Support of Science and Research that was in operation since 2010, 
which supports scientific research through personal grants, awards and popularization 
events and which has allocated a total of €1m (CZK 29.5m) over its life-time so far. 
3.3.2 Funding sources and funding flows 
The role of the EU Structural Funds in the public funding of R&D has grown enormously 
in the programming period 2007-2013 (Mana and Štampach, 2015). Public national 
sources edged up by only about 19% from €854m (CZK 23.5b) in 2010 to €1,017m 
(CZK 28.0b) in 2010, the increase of which is in fact primarily due to co-financing of the 
EU Structural Funds that is included in these figures and the most of which is 
concentrated in the central government; the regional and local funding remains 
miniscule. The EU funding sources, predominantly the EU Structural Funds (ERDF and 
ESF) channelled through the OPs at the MEYS and MIT, recorded a six-fold increase from 
a €80m (CZK 2.2b) in 2010 to €483m (CZK 13.3b) in 2014 and amounted to the total of 
about €1,663m (CZK 45.8b) over 2010-2014.   
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From this follows that the share of the EU funds in the total public R&D funding nearly 
quadrupled from 8.6% in 2010 to 32.2% in 2014, which makes it by far the most 
dynamic funding source over this period. The EU Structural Funds became instrumental 
mainly for upgrading of the research infrastructure. Other sources of public transnational 
funding are negligible. 
Czech participants active in projects funded under the 7th Framework Programme (FP7) 
acquired from the EU support of €290m in 1,153 projects with 123 coordinators, which 
represents a sizeable increase as compared to the 6th Framework Programme with the 
EU support of €139m in 890 projects with 38 coordinators only. H2020 participation, 
which is at an early stage, seems judging by the funding of contracts already signed 
relatively to the EU28 total to be generally in par with the FP7 participation. At the 
system level, the EU FP funding has been of rather minor importance, especially if 
compared to the large amount of funding channelled through the EU Structural Funds. 
Nevertheless, the EU FP sources were relevant for particular research performers, such 
as top research workplaces in the HEIs and PROs located in Prague that did not have 
access to the EU Structural Funds due to GDP per capita well above the EU28 average in 
the capital city region. 
In 2014, the domestic business sources financed 36% of GERD and the foreign business 
sources financed 15% of GERD. As much as 97% of the domestic business R&D funding 
was spent by the firms themselves, hence only 3% flew elsewhere, which testifies to the 
very weak link between the business sector and other parts of the system; this 
proportion remained remarkably stable over the last ten years. Somewhat surprisingly 
foreign business R&D funding tends to be more open with 11% being spent outside of 
the business sector, almost all of which goes to the PROs and only a negligible amount 
ends up in the HEIs (CZSO, 2015a). 
R&D performed by foreign affiliates amounted to €974m (CZK 26.8b) in 2014 and grew 
by 10% to 20% annually since 2010. BERD is characterised by a level of domination by 
foreign-owned companies that is one of the highest in the EU, as about 56% was 
performed by foreign affiliates in 2014 up from 51% in 2011 but slightly down from 57% 
in 2008. Likewise, BERD funding from foreign business sources increased rapidly, in fact 
nearly tripled, from €148m (CZK 4.1b) in 2010 to €410m (CZK 11.3b) in 2014, thus 
financed nearly a fifth of BERD already (CZSO, 2015a). Even though individual data are 
not available for confidentiality reasons, it is well known that most of the largest 
business R&D spenders, probably all of the top five, are foreign affiliates, including 
Škoda Auto, Honeywell, Škoda Transportation, Zentiva and Bosch.  
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3.4 Public funding for public R&I 
3.4.1 Project vs. institutional allocation of public funding9 
Public R&D funding has been traditionally dominated by institutional support. However, 
this has changed in the context of the Reform of the RDI System that has been launched 
in 2008. As a result, according to the official classification used by the CRDI the share of 
project funds increased markedly in the last few years, namely from 44% in 2009 to 
51% in 2014 (CRDI, 2015a). However, in fact the true share of project funding was 
higher, probably in the range between 55% and 60% in 2014, because several items 
officially recorded under the heading of institutional funding, such as co-financing of the 
EU Structural Funds administered by the MEYS and MIT or support to projects of 
international cooperation under the MEYS, do not necessarily meet the definition.  
Despite the Reform of the RDI system, the balance between thematic and generic 
funding has remained remarkably stable; oscillating in a narrow range between 58% and 
61% share of generic funds in GBAORD over the period 2008-2012 (Eurostat, 2014). 
Until very recently the allocation of thematic funding has only loosely reflected the 
national priorities and grand challenges. Yet this is changing with implementation of the 
updated priorities of oriented R&D for the period until 2030 (CRDI, 2012), which are 
designed to reflect major societal challenges in line with in the Horizon 2020, and which 
start to be respected in the thematic focus of new support programmes, such as in the 
recent calls of the ALFA and OMEGA programmes of TACR and the new TRIO programme 
of MIT that explicitly require the proposals to address the national priorites, and 
prospectively also in allocation of institutional funding. None of the existing policy 
documents, however, sets binding targets in this respect. 
3.4.2 Institutional funding  
In 2009, early in the reform a new fully performance-based methodology for evaluation 
of R&D results and distribution of institutional funding was introduced. The methodology 
was based exclusively on quantitative indicators. It has been decided that each provider 
receives institutional funds based on historical research results achieved over the past 
five years, as reported to the IS VaVaI. However, the new system has been heavily 
criticized by the academic community among other things for being too mechanistic, for 
not taking into account differences in publication behaviour between fields of science and 
for creating unstable funding conditions. The International Audit of Czech RDI concluded 
that the evaluation methodology is not fit for its purpose and recommended a 
fundamental revision (Arnold, 2011). 
A medium term modification of the evaluation methodology of research outputs has been 
introduced for the period 2013-2015, the so-called Metodika 2013 (CRDI, 2013b), on the 
base of which institutional funding is going to be allocated at least until 2017. Pillar I 
remains the same as before using formulae-based procedure of assigning points to 
publications. Newly introduced Pillar II involves international peer review by expert 
panelsof a list of top outputs submitted by the evaluated organisations.   
                                          
9 "Institutional funding is defined as the total of national budgets in a given country, attributed to 
an institution, with no direct selection of R&D project or programmes and for which money the 
organisation has more or less freedom to define the research activities to be performed." 
Institutional funding can be in the form of non-competitively allocated Block funding. Institutional 
funding may also be allocated in a variable/competitive manner tied to institutional assessments. 
"project funding is defined as the total of national budgets in a given country, attributed to a group 
or an individual to perform an R&D activity limited in scope, budget and time, normally on the 
basis of the submission of a project proposal describing the research activities to be done". Steen, 
J. v. (2012), “Modes of Public Funding of Research and Development: Towards Internationally 
Comparable Indicators”, OECD Science, Technology and Industry Working Papers, 2012/04, OECD 
Publishing. http://dx.doi.org/10.1787/5k98ssns1gzs-en.  
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Moreover, extra bonuses are awarded to research organisations, which obtained project 
funding from the European Research Council (ERC). Pillar III considers outputs of applied 
research, predominantly patents, and takes into account external funding acquired for 
applied research and contractual research.. The revised methodology at least partly 
removes the highly criticized shortcomings of the previous evaluation system, though; 
the evaluation continues to heavily rely on the formulae-based allocation of points for 
outputs. In 2014, for instance, the distribution of awarded evalution points was 74%, 
11% and 15% between pillars I. II. and III., respectively.  
In 2015, the government decided to prolong the validity of Metodika 2013 until the end 
of 2016 and to merge the evaluation for the years 2014 and 2015, which henceforth will 
be conducted jointly during 2016. For this purpose Metodika 2013 undergone a revision 
process in 2015, which however was aimed at rather minor parametric changes, 
predominantly related to its implementation that do not require a formal approval of the 
government. After 2016 a new system of RDI evaluation and distribution of institutional 
funding that has been prepared within the IPN Metodika project is expected to be 
gradually implemented. The proposed evaluation methodology is based on an informed 
peer-review, comprises of five main components: i) Research environment; ii) 
Membership of research community; iii) Scientific research excellence; iv) Overall 
research performance; and v) Societal relevance, and takes into account different roles 
of research organizations in the national system. The proposed funding principles divide 
institutional funding into segments devoted for the different types of research 
organizations, which is for each recipient sub-divided into a block grant, a performance 
agreement and a performance-based research funding system using the evaluation 
scores; the latter two performance-based parts account for 20% and the block grant that 
refers to an average of what the organization received in the previous 3-5 years for 80% 
of the funding. Nevertheless, a roadmap for the implementation has not been announced 
yet. 
According to the initial reform plans, almost the full amount of institutional funding was 
supposed to be allocated using the performance-based formulae. However, in order to 
stabilize the funding flows, a consensus has been reached that only 20% of the money is 
allocated using the evaluation results, hence competitively, while 80% of the money is 
divided in the same proportion as in the previous year, hence representing block 
funding. Metodika 2013 does not include explicit rules for allocating the institutional 
support anymore, which is a major departure from the previous funding mechanism in 
the sense that institutional funding is not supposed to be automatically allocated based 
on the evaluation results Hence, the evaluation system is performance based but the 
evaluation results only provide background information for budget decisions and 
institutional funding is in fact distributed according to budget negotiations among actors. 
In 2014, the single largest recipient of institutional funds was the CAS with €163m 
(CZK4.5b), which constituted 34% of the national total; however, the CAS increasingly 
acquires funding from other sources than its own public budget line (CAS 2015). It is 
important to note that the institutional funds that are allocated to the CAS in its own 
public R&D budget line become re-distributed between the member research institutes 
using results of its own internal evaluation methodology that involves international peer 
review, which is conducted every five years and the most recent round of which has 
been performed in 2015. Overall, however, the largest share of the national institutional 
funding, about 44% and €203m (CZK5.6b) in 2014, is channelled to the sector of higher 
education by the MEYS, which distributes the funds among the individual higher 
education research organisations using results of the formulae-based evaluation of 
Metodika 2013. Much smaller amounts are channelled through other ministries which 
predominantly use the institutional funds to support field-specific research centres under 
their own umbrella (the Ministry of Agriculture, the Ministry of Health, the Ministry of 
Culture, and others).   
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National public co-financing of the EU Structural Funds dealing with R&D and innovation 
that is administered by the MEYS and MIT and that amounted to €51m (CZK1.4b) in 
2014 is also classified under the category of institutional funding in the public R&D 
budget 
3.4.3 Project funding 
GA CR allocates grants for basic research with an annual budget of €127m (CZK 3.5b) in 
2014, which more than doubled from €55m (CZK 1.5b) in 2008. GA CR uses 
international peer review to guide the allocation of funds. The main funding instrument is 
a standard grant project, to which are allocated nearly three-quarters of the budget thus 
nearly €100m in 2015, the call for which is announced annually and can have duration of 
1-3 years. Other funding instruments with much smaller budget allocations include 
projects for excellence in basic research, postdoctoral grants, junior grants and 
international bilateral grants.  Applications are assessed by an expert panel (39 panels in 
5 disciplinary areas) on the base of two-step review procedure; first, the applications are 
evaluated by two internal reviewers and then only those that satisfy minimal quality 
requirements (about half of the applications) are evaluated by at least two foreign 
reviewers (Slovaks are not perceived as foreigners). The main evaluation criteria are 
research novelty, quality of the proposal, management of the project and track-record of 
the coordinator. The success rate ranges between 15 to 30%, depending on the program 
and year. 
The MEYS also has a significant budget devoted to project-based funding, which is 
directed primarily towards the higher education sector, including the competitively 
allocated funding for research conducted by master and doctoral students – the so-called 
“specifický výzkum” – with a budget of €44m (CZK 1.2b) in 2014, each university 
divides the funding for “specific research” within using its own selection criteria mostly 
based on internal and/or domestic peer review, there are no plans to transfer this 
funding under the GA CR. 
Five other ministries also provide project funding to research in the public sector through 
their individual research programmes, namely the Ministry of Agriculture, the Ministry of 
Culture, Ministry of Defence, Ministry of Health and Ministry of Interior; however, the 
amounts are much smaller and  past experience has shown, that these programmes, 
while nominally project funds, are often used as a source of institutional funding for 
research institutes controlled by the given ministries and also as means of research 
funding for the needs of these ministries. 
Most programmes of project funding in the public sector, for example the GA CR and 
MEYS grants, provide funding to bottom-up projects broadly across most fields of 
science, hence there is little priority setting and the funding does not explicitly respond 
to societal challenges, at least as far as the project selection criteria are concerned. 
Evaluations of these programmes according to international standards have never been 
performed, thus little in known about their impact on the target groups, effectiveness 
and efficiency. All project funding is formally allocated to the organization of the project 
coordinator; there are no person bound grants that the individual recipient could transfer 
to a different organization. 
3.4.4 Other allocation mechanisms 
Other mechanisms that provide public funding to public R&I but cannot be classified as 
project or institutional funding are rare. BETA programme of TA CR assigns competitively 
public procurement in RDI for the needs of public administration bodies, the recipients of 
which may (or not) be research performers in the public sector, hence this is a tool for 
governmental organizations to obtain contract research.  
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3.5 Public funding for private R&I  
3.5.1 Direct funding for private R&I 
The dominant providers of direct national funding to stimulate private R&I are the TA CR 
and MIT, the combined amount of subsidies channelled by which amounted to about 
€150-200m (CZK 4-5b) annually over the period 2010-2014. Five other ministries, 
namely the Ministry of Agriculture, the Ministry of Culture, Ministry of Defence, Ministry 
of Health and Ministry of Interior, provide direct R&I subsidies available to recipients 
from the private sector but with noticeably smaller budget allocations of a combined 
value of €94m (CZK 2.6b); most of which in fact does not end up being distributed to 
private entities. Several regions have implemented innovation voucher programmes 
since 2012; however, their funding has been limited to a combined value of less than 
€1m (CZK 26m) annually, hence very small so far. 
In recent years, the focus of innovation policy started to shift from supporting internal 
R&D in firms to stimulating public-private research cooperation and commercialization of 
research results. At the forefront of this transformation is the wave of new programmes 
implemented by TA CR, which was established in 2009. The programme ALFA that 
supports business R&I projects and stimulates public-private research cooperation 
started to fund first projects in 2011. Competence Centres programme that funds joint 
public-private RDI centres in progressive fields with strong application potential was 
launched in 2012. Two additional programmes started in 2014, namely GAMA supporting 
the practical application and commercialization of R&D results and DELTA for joint 
international projects in applied research with third countries. EPSILON that replaces 
ALFA started in 2015. As a result, the budget of TA CR has grown significantly from 
€33m (CZK 0.9b) in 2011, to €109m (CZK 3.0b) in 2014. TA CR evaluates project 
proposals using peer-review but only with the help of domestic experts. TA CR 
programmes increasingly pay attention to the national R&I priorities that respond to 
societal challenges.  
The major part of funding for private R&I used to be administered by the MIT, primarily 
through the TIP research programme the budget of which, however, has been 
significantly reduced with expenditures of €109m (CZK 3.0b) in 2012, €73m (CZK 2.0b) 
in 2013 and €40m (CZK 1.1b) in 2014, and is earmarked to continue shrinking in the 
medium-term budget outlook. From 2017 onwards the MIT was supposed to cease to 
administer competitive funding from the national public R&D budget and completely pass 
this role to the TA CR. Nevertheless, this has been reversed in 2015, when the 
government approved TRIO programme at MIT for support of business R&I and public-
private research collaboration in key enabling technologies with a budget of €134m over 
2016-2021. Hence, MIT is taking back its original role of the major provider of direct 
subsidies to business R&I. Attention to support of RDI in industrial enterprises from 
start-ups to mature enterprises and fostering public-private linkages has been also paid 
in the sub-programmes Innovation, Potential, Cooperation and ICT and Strategic 
Services of the OP EI administered by the MIT.  
Arnold (2011) heavily criticized the poor quality of national R&I programme evaluation. 
Yet there has been little progress since then. Metodika 2013 devoted only two pages to 
evaluation of R&I support programmes, which in any case is limited to ex-post 
descriptive overviews of their inputs and outputs derived from program monitoring, 
hence the existing evaluation framework does not provide much need strategic 
intelligence for programme development; next to nothing is known about their impacts. 
In fact, there has never been evaluation of national R&I programme that meets 
minimum international evaluation standards, not mentioning counterfactual impact 
evaluation and/or econometric analysis of additionality effects.  
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Public Procurement of Innovative solutions 
In 2014 the total market of public procurement in Czech Republic was equal to Kč577b 
(€21b) or approx. 13% of the GDP with 78% of the volume registered in the Public 
Procurement and Concession Portal ISVZ. The total value of R&D public procurement 
contracts in the Czech Republic was about Kč1.1b (€40.5m) for products and services in 
201410. 
Legal context 
The Directives 2004/17/EC and 2004/18/EC were transposed into Act no. 137/2006 Coll. 
on Public Contracts and Act no. 139/2006 Coll. in Concession Contracts and Concession 
Procedures (Concession Act), and include a comprehensive framework for electronic 
public procurement.  
In pursuance of the SEC (2004) 1639 Communication the Czech Republic adopted 
resolution no. 500 on 10 May 2006 and adopted the National Plan for the Introduction of 
Electronic Public Procurement over the Period 2006-2010. Decrees no. 326/2006 Coll 
and 329/2006 Coll. lay down the requirements on Attestation Procedure for Electronic 
Tools and Electronic Means, Electronic Tools and Electronic Acts in Public Procurement11. 
Furthermore, if the public procurement act allows the exception, the Act No. 130/2002 
Sb on support of research, experimental development and innovation with public funds, 
and amending certain related laws can be directly applied.  
A new act on Public Procurement is now discussed in the lower chamber of the 
parliament and its adoption is foreseen by April 201612. 
The PCP/PPI landscape in the Czech Republic 
Public tenders in the Czech Republic, except of those for R&D, are very rarely recognised 
as the opportunity to promote innovation. A national target on public procurement of 
innovative goods and services has not been announced. The national procurement policy 
does not mention innovation support as its objective. 
Public procurement in R&D for the needs of public administration bodies is centralised 
under the BETA programme of the Technological Agency of the Czech Republic. 
For the years 2011 and 2012 TACR selected 101 themes for which the agency either 
announced public tenders or prepared tender proceedings. Due to the large number of 
announced public tenders, the complexity of the tender proceedings and the associated 
rigid administrative duties TACR proposed to simplify the process both in terms of the 
themes (research needs) and the tender procedure. These and other proposals for 
amendments were contained in a draft amendment to the BETA programme, which was 
submitted to the Government for approval in early 2013. 
The research needs must contribute to the fulfilment of at least one of the specific 
objectives of the programme or specific objectives set by the relevant governmental 
body.  
A national target on public procurement of innovative goods and services has not been 
announced. The national procurement policy does not consider the objective of 
supporting innovation.  
                                          
10 http://www.portal-vz.cz/getmedia/e404b766-77d0-488b-8809-6951c53c0eb9/Vyrocni-zprava-
o-stavu-verejnych-zakazek-v-Ceske-republice-za-rok-2014_final.pdf  
11 http://www.portal-vz.cz/en/Jak-na-zadavani-verejnych-zakazek/Elektronicke-zadavani-
verejnych-zakazek/National-Documents  
12 Petr Kadlec, Workshop on the legal framework of Innovation Procurement in Europe, Brussels 
2015. 
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The standard procedure pursuant to Act on Public Procurement is used to select the bids 
for the public tenders for the research needs approved from 2013. The length of projects 
(fulfilment of the public tenders) in the BETA programme from 2013 is between 6 and 36 
months. The cost of the project is limited by the programme resources, and the 
resources allocated to the relevant government bodies. The support for projects in the 
BETA programme is 100 % of the total eligible costs. The total budget for the whole 
duration of the programme amounts Kč640m.  
Czech procurers participate also in the networking project COMPLETE that prepares the 
ground for PPI on novel optical networking solutions (Czech education and scientific 
network CESNET). 
3.5.2 Indirect financial support for private R&I 
Since 2005 the Ministry of Finance (MF) operates a system of tax incentives that allows 
firms to deduct expenditures on R&D carried out in-house from their tax base. In 2005, 
33% of R&D performing businesses used the tax relief and the indirect support of R&D, 
i.e. the tax revenue foregone by the state, amounted to €27m (CZK 0.82b). In 2013, 
51% of business R&D performers draw on indirect support to R&D and the indirect 
support of R&D reached €84m (CZK 2.30b). Nearly 80% of firms that use the indirect 
R&D support have less than 250 employees and about 70% of them are domestic-
owned; hence this instrument proves to be particularly suitable for promoting R&D in 
domestic SMEs (CZSO, 2015b). 
The primary objective of the R&D tax credit scheme is to stimulate private expenditure 
on intramural R&D. It has been recognized, however, that this form of tax deduction is 
going against the need to intensify collaboration between the business sector and 
academia. Hence, starting from 2014 the indirect fiscal support through R&D tax credits 
was extended to the purchase of external R&D services from research organizations with 
the aim to stimulate public-private linkages. The expansion of scale and scope of R&D 
tax credits has not lead to a reduction of direct public funding for private R&I, at least 
this has been seldom raised in the debates about public support to business R&D. So far 
there has not been any evaluation of this support scheme.  
3.6 Business R&D 
3.6.1 The development in business R&D intensity 
The Czech BERD has been following a growing trend since 2005 with a small decrease in 
2009 and in 2014 reached over 1% of the GDP (1.12%) (see Figure 10). 
In 2013 the service and manufacture sectors amounted together to more than 90% of 
the Czech BERD (38% and 57% respectively). The manufacture is strongly correlated to 
the total BERD.. 
The business sector (Figure 11) is by far the main funder of the Czech BERD (0.69% of 
the GDP in 2014). The contributions from abroad gained on importance increasing from 
0.04 in 2005 to 0.32% in 2014, i.e. currently funding about one fourth of the total BERD. 
The government funding remains fairly stable, oscillating between 0.11-0.14 in 2005-
2014 and was at 0.11% in 2014, i.e. an intensity much lower than of the business sector 
and abroad funding. 
The R&D performed by foreign affiliates amounted to €974m (CZK 26.8b) in 2014 and 
grew by 10% to 20% annually since 2010. The Czech BERD is characterised by a level of 
domination by foreign-owned companies that is one of the highest in the EU, as about 
56% of the total BERD was performed by foreign affiliates in 2014 up from 51% in 2011 
but slightly down from 57% in 2008.   
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What is more, the R&D investments of the foreign-owned companies are highly 
concentrated in small number of sectors and small number of firms, the R&D of domestic 
companies is more equally distributed (the average annual expenditure for performed 
R&D per company in the foreign-controlled enterprises totalled CZK 37m, in the 
domestic private enterprises it was nearly 4 times less, i.e. CZK 9.7m (CDRI 2015).  
Another factor of distinction is the fact that foreign-owned companies financed more 
than 95% of their R&D expenditures in 2012 from private sources (domestic and foreign) 
whereas domestic firms use more often the public funds to finance their R&D activities 
(almost one third of the total expenditure). 
As much as 97% of the domestic business R&D funding was spent by the firms 
themselves, hence only 3% were contracted out, which testifies to the very weak link 
between the business sector and other parts of the system; this proportion remained 
remarkably stable over the last ten years. 
Even though individual data are not available for confidentiality reasons, the largest 
business R&D spenders are foreign affiliates such as: Škoda Auto, Honeywell 
(engineering), Škoda Transportation, Zentiva (pharmaceutical) and Bosch (engineering 
and electronics and three Czech companies: České dráhy (Czech Railways), the ČEZ 
Group (industrial transportation) - both with the state as major shareholder) and Aero 
Vodochody (airospace manufacture). The latter are listed in the EU Industrial R&D 
Investment Scoreboard 2015. 
 
 
Figure 10 BERD intensity broken down by most important macro sectors (C= 
manufacture, G_N=services) 
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Figure 11 BERD by source of funds 
3.6.2 The development in business R&D intensity by sector 
The automotive sector is the leading sector of the Czech manufacture (Figure 12), 
followed by engineering sectors, i.e. the manufacture of machinery and equipment and 
the repair and installation of machinery and equipment.  
For the three sectors mentioned above we observe an increasing trend since 2011 but 
with the sharpest growth for the automotive sector. In the period of 2009-2010 both 
automotive and manufacture of machinery and equipment experienced a slight decrease 
possibly linked due to the global financial and economic crisis, which had also an impact 
on business investment in R&D. 
In the automotive industry the main player is Škoda Auto that is responsible for around 
80% of the total investment in the automotive sector (CDRI 2015).  
 
 
Figure 12 Top sectors in manufacturing (C28=manufacture of machinery and equipment 
n.e.c.; C29=manufacture of motor vehicles, trailers and semi-trailers C33 Repair and 
installation of machinery and equipment) 
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As far as the services are concerned, we notice the importance of the professional, 
scientific and technical activities and the ICT with similar growth till 2012. In 2013 we 
observe a decrease only for professional, scientific and technical activities. It has to be 
noted that this sector is rather peculiar given the fact that many of these R&D companies 
were created from the former departmental research institutes that were privatised after 
1989 and therefore account for a significant amount of the Czech R&D service sector. In 
all three sectors smaller private domestic businesses dominate. 
 
 
Figure 13 Top service sectors (J=information and communication, G=wholesale and 
retail trade; repair of motor vehicles and motorcycles, M=professional, scientific and 
technical activities). 
3.6.3 The development in business R&D intensity and value added 
Unsurprisingly, due to its importance in the Czech BERD, manufacturing is the biggest 
contributor to Gross Value Added (GVA) in the Czech Republic in 2012 (Figure 14). The 
wholesale and retail trade, repair of motor vehicles and motorcycles is the top service 
sector in terms of GVA. It is however only third sector in terms of BERD with much lower 
intensity and not growing dynamically as the ICT and professional, scientific and 
technical activities.  
Finally, we notice the importance of some services (like the real estate activities, 
construction and the activities related to human health) in terms of their GVA, whereas 
they play a modest role in the BERD.  
Consistently with the aforementioned importance of the automotive industry in the 
Czech economy, the manufacture of machinery and motor vehicles is the leading sector 
also in terms of GVA for the Czech manufacture. Other important sectors in terms of 
GVA but not in terms of BERD intensity are manufacture of fabricated metal products, 
except machinery and equipment, manufacture of food products; beverages and tobacco 
products. The third and fifth manufacturing sector in terms of GVA - manufacture of 
machinery and equipment n.e.c. and manufacture of electrical equipment is also 
important in terms of BERD. 
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Figure 14 Economic sectors as percentage of the total GVA. Top 6 sectors in decreasing 
order: 1) manufacture, 2) wholesale and retail trade (repair of vehicles and 
motorcycles), 3) real estate activities, 4) public administration and defence, 5) 
construction, 6) professional, scientific and technical activities 
 
Figure 15 GVA in manufacturing. Top 6 manufacturing sectors: 1) manufacture of 
motor vehicles, trailers and semi-trailers 2) Manufacture of fabricated metal products, 
except machinery and equipment, 3), Manufacture of machinery and equipment n.e.c., 
4) Manufacture of food products; beverages and tobacco products 5) Manufacture of 
electrical equipment, 6) Manufacture of rubber and plastic products. 
 
Figure 16 Value added at factor cost for the leading manufacture and service sectors in 
Figures 3 and 4  
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Figure 16 shows the value added for the top manufacture and service sectors. We notice 
the dominance of the services of the automotive sector, which are clearly set apart from 
the other services and manufacture sectors. 
The number of researchers employed in business is growing in all major sectors, most 
dynamically in the ICT sector. It is however worth noting that business employs a very 
low rate of women researchers. In 2012 women accounted for only 19% of the R&D staff 
in the business sector, among the lowest results in the European countries (CDRI 2015). 
3.7 Assessment 
The R&D activity of Czech enterprises reached for the first time over 1% of the GDP in 
2014. It was growing steadily since 2010 and the recent increases were gained mostly 
thanks to the inflows of funding from abroad. The Czech business R&D is largely 
performed by foreign-owned companies and concentrated in the high and medium-tech 
sectors (automotive and engineering). On the contrary, the R&D in services (information 
and communication services, services related to automotive services and professional 
and scientific activities) is more often performed by domestic companies.  
According to the International Audit of Czech RDI (Arnold, 2011, pg. 56), the share of 
project funding allocated competitively was too high, exceeding proportions that many 
countries deem as dangerous, and one of the key recommendation was that in order to 
assure stability and opportunities for long-term planning institutional funding should 
comprise at least 50% of the public R&D budget. Despite initial reform plans to reach 
60% to 40% ratio between project (or targeted) and institutional funding by 2015, the 
policy has been updated in this respect and the ratio has stabilized around 50% over 
2012-2015 and is projected to remain roughly at the same level in the medium-term 
budget outlook until 2018. As 80% of institutional support has become block funding and 
only 20% continues to be competitively allocated on performance criteria, the funding of 
research organizations has been stabilized in recent years. Nevertheless, due to the 
problematic evaluation methodology, decisions on changes in the distribution of 
institutional funding among the main providers started to be based on budget 
negotiations and political agreements rather than performance.  
The predominantly formulae-based evaluation of research organizations, on which 
allocation of institutional funding is supposed to be based, aims to incentivise both 
increased output and scientific quality, but largely succeeds in promoting only the 
former, possibly at the cost of undermining the latter. The evaluation methodology 
invites gaming behaviour in maximizing the evaluation “points” for pre-defined outputs 
without the regard for purpose and impact.  
Other important concerns, such as research environment, human resource management, 
international networking and societal relevance, tend to be overlooked. Metodika 2013, 
which added small bonuses for top outputs and acquiring external funding, was a step in 
the right direction, but did not fix the key problems that contribute to the sub-optimal 
functioning of the research system. IPN Metodika proposed a far more complex and 
satisfactory methodology of both evaluation of research organizations and allocation of 
institutional funding, however, a clear political decision on its implementation has not 
been made so far. The dispute among the key stakeholders over the evaluation 
methodology represents a major impediment for tackling other problems that are related 
to it. 
Until recently the government stimulated RDI in the private sector predominantly 
through the traditional direct subsidies to internal R&D activities. Yet there has been a 
positive shift towards a wider portfolio of support measures. R&D tax credits significantly 
expanded in both their scale and scope. New measures were introduced that promote 
joint public-private circulation, collaboration and transfer of knowledge. More attention is 
paid to supporting commercialisation of research results and innovation activities at 
large.   
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Nevertheless, venture capital market is underdeveloped and public measures to boost 
the access to venture capital through the establishment of public-private seed fund have 
failed so far; there are plans to re-launch this effort, the results of which remain to be 
seen. Evaluation of public R&I support programmes is underdeveloped, hence there is 
only anecdotal evidence on the extent to which direct and indirect public financial 
support to business R&I succeeds in leveraging business R&I expenditure.  
Generally speaking, the key challenge that needs to be addressed for achieving more 
efficient and effective functioning of the funding allocation system is the underdeveloped 
evaluation culture.  As also pointed out by the International Audit of Czech RDI (Arnold, 
2011, pg. 56), the system of R&D evaluation is grossly outdated, focused on counting 
outputs rather than aiming at assessing policy interventions, outcomes and their 
impacts, and hence provides limited feedback to the policy and programme 
development; there is a need for a fundamental upgrade of evaluation practices.  
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4. Quality of science base and priorities of the European 
Research Area  
4.1 Quality of the science base 
According to European Commission (2015a and 2014c), in particular the quality of 
scientific production and technological development, in other words the level of 
excellence in S&T, is markedly behind than the EU28 average and changing very slowly. 
On one hand, there is clearly a catching up trend in research productivity with the EU28 
average, but on the other hand the research and innovation system as a whole still lags 
behind the EU28 average in terms of top research outputs, such as highly cited scientific 
publications and international patents, per capita or per GDP. As far as these high-
quality R&D outputs are concerned, there are several fields that stand out, including 
organic chemistry, nuclear physics, medical sciences, textile materials, machine tools, 
electrical engineering, combustion engines and vehicles in general.  
In 2013, the Czech Republic produced 1.73 publications per 1,000 population, slightly 
above the EU28 average (1.43), of which 37.6% were internationally co-published, 
which is the seventh lowest share in the EU28. The Czech Republic had 0.65 
international scientific publications per 1,000 population, which roughly corresponds to 
the EU28 average. In 2010 only about 9% of the Czech scientific publications were in the 
top 10% most cited publications worldwide, however, well below 12.3% of top scientific 
publications produced in the EU28. In the period 2011-2013, the share of public-private 
co-publications was 1.0% in the Czech Republic against 1.8% in the EU28. Overall, 
therefore, the quantity of scientific publication outputs is already in par or even exceeds 
the EU28 average, however, the quality of research continues to lag behind. 
One aim that has been repeatedly stressed is promoting excellence in research. Yet this 
has been grossly mismanaged by introducing the formulae-based system of evaluation of 
research institutions, regardless of other concerns. Arnold (2011) recommended that the 
evaluation practice should be the subject of root and branch reform, refocusing on 
outcomes and impacts in addition to outputs. The latest modification of the evaluation 
methodology, the so-called Metodika 2013 (CRDI, 2013b), established two new pillars 
that involve international peer review and bonuses for research excellence; however, the 
formulae-based pillar remains dominant. IPN Metodika project has prepared preparing a 
new more complex evaluation methodology, however, the roadmap for implementation 
of which has not been set yet.  
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Indicator Year EU-28 
Number of publications per 
thousand of population 
1.73 (2013) 1.43 (2013) 
Share of international co-
publications 
37.6% (2013) 36.4% (2013) 
Number of international 
publications per thousand of 
population 
0.65 (2013) 0.52 (2013) 
Percentage of publications in 
the top 10% most cited 
publications 
8.98 (2010) 12.25 (2010) 
Share of public-private co-
publications 
1.0% (2011-2013) 1.8% (2011-2013) 
Source: JRC IPTS RIO elaboration on Scopus data collected by Sciencemetrix in a study 
for the European Commission DG RTD (Campbell, 2013). The share of public-private co-
publications is derived from the Scival platform and is also based on Scopus data 
(September 2015). SciVal ® is a registered trademark of Elsevier Properties S.A., used 
under license. The data on public-private co-publications is not fully compatible with the 
data included in the IUS, due to differences in the methodology and the publication 
database adopted. 
4.2 Optimal transnational co-operation and competition 
4.2.1 Joint programming, research agendas and calls 
In the context of the National Policy of RDI 2009-2015 implementation, new long-term 
national priorities of oriented RDI (for the period until 2030) that are largely in line with 
the grand challenges of Horizon 2020 were prepared by panels of experts at the end of 
2011 and approved by the government in mid- 2012 (CRDI, 2012). More specifically, the 
priority research fields were identified within six broader areas: i) Competitive 
knowledge-based economy; ii) Sustainable energy and material resources; iii) 
Environment for quality life; iv) Social and cultural challenges; v) Healthy population; 
and vi) Safe society. The governmental ministries, CAS, GA CR and TA CR have 
responsibility for implementing these priorities within their authority and they have been 
taken into account in the national R&I budget expenditures from 2014 onwards.  
The Czech Republic participates in the European Space Agency, the European South 
Observation, the European Molecular Biology Conference, EUROATOM, EFDA and other 
programmes. MEYS manages a number of programs that support within EU cooperation 
in research, for instance EUREKA CZ, COST CZ, EUPRO II and INGO II. As a member of 
the European Science Foundation, GA CR coordinates and co-funds its programs in the 
European Collaborative Research (EUROCORES) framework; these programs comprise 
less than 1% of GA CR budget. GA CR further provides funding for international bilateral 
research grants, including with the neighbouring Deutsche Forschungsgemeinschaft in 
Germany and Fonds zur Förderung der wissenschaftlichen Forschung in Austria; 
however, the combined funding comprises only less than 2% of GA CR budget. The 
Visegrad fund and the Financial Mechanisms of the EEA/Norway also promote research 
cooperation with the respective countries.  
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The National Information Centre for European Research (NICER) that operates under the 
Technology Centre of the CAS provides comprehensive support for the participation of 
national teams in international research cooperation, especially in the EU Framework 
Programmes. The Czech Liaison Office for Research, Development and Innovation 
(CZELO) in Brussels supports the successful integration of the Czech research into the 
European research cooperation, particularly through the EU Framework Programmes for 
Research and Development. The office provides free services to researchers from all 
fields and all research bodies in the Czech Republic. CZELO is a project managed by the 
Technology Centre of the CAS and financially supported by the MEYS. 
The Czech Republic has become a member of five Joint Programming Initiatives (JPIs), 
all four from the first wave of 2009 and only one from the second wave of 2010: 1) 
Neurodegenerative Disease Research, 2) Agriculture, Food Security and Climate Change, 
3) Cultural Heritage and Global Change, 4) Healthy Diet for a Healthy Life and 5) The 
Microbial Challenge – An Emerging Threat to Human Health. However, the Czech 
Republic plays a rather passive role in the JPIs. The Czech Republic is also formally 
engaged in all five Joint Technology Initiatives (JTIs).  
According to Acheson et al. (2012), the main constraints regarding to Czech participation 
in the JPIs are budgetary restrictions, limited human resources, lack of coordination at 
the national level and insufficient compatibility of the national and European rules and 
procedures. It is therefore no wonder that albeit there are several programmes at the 
national level which support research on topics relevant to the strategic research areas 
of the JPIs, the national funding providers have not come forward with direct 
involvement in terms of financial participation so far. Šebková, et al. (2011) conclude 
that national financial support to joint programs is very low; ERA-NETs funding is close 
to zero and bilateral agreements account for a very low part of research funding. Overall, 
there is a weak link between the Czech joint programmes on one hand and the European 
programs on the other hand. Not much has changed in this respect in recent years. 
4.2.2 RI roadmaps and ESFRI 
The Czech Republic is a member of projects of large European infrastructures (ESFRI). 
The Roadmap for Large Research, Development and Innovation Infrastructures in the 
Czech Republic was approved by the Government in March 2010 and updated in May 
2011 and May 2015 (MEYS 2011 and 2015a). Several large research infrastructural 
projects financed by the OP RDI, including pan-European infrastructures, are under 
construction and gradually opening, which have a potential to open new avenues for 
international co-operation:  i) ELI - Extreme Light Infrastructure (€271m); ii) BIOCEV - 
Biotechnology and Biomedicine Research Centre (€92m); iii) CEITEC - Central European 
Institute of Technology (€209m); iv) Centrum excellence IT4Innovations (€72m); and v) 
ICRC - International Clinical Research Center (€94m); vi) SUSEN - Udrzitelna energetika 
(€97m).. 
National program sustainability I. and the prospective National program sustainability II. 
have been established to secure immediate funding for operation of the newly 
constructed research centre and infrastructure projects until 2020. Nevertheless, their 
funding demands are expected to send ripples throughout the public research sector, as 
according to preliminary estimates their operating expenses may account for as much as 
one fifth to one third of the current public R&I budget. Hence, the induced pressures in 
allocation of institutional funding and the broader picture of their integration into the 
national system remains a challenge. Unless the amount of public R&D outlays is 
significantly expanded, which is not expected in the medium-term outlook, public 
research organisations, including the newly build projects, may end up being 
underfunded.  
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4.3 International cooperation with third countries 
The Czech Republic maintains a number of bilateral agreements with third countries 
either on intergovernmental level or on inter-institutional level, involving, for instance, 
GA CR, TA CR and CAS. MEYS which is the main intermediary body responsible for 
international cooperation in research manages programme KONTAKT II devoted to 
financing bilateral projects based on intergovernmental agreements with a host of third 
countries and programme GESHER/MOST for bilateral project with Israel. GA CR provides 
funding for international bilateral research grants with National Research Foundation of 
Korea of South Korea and Ministry of Science and Technology of Taiwan. TA CR operates 
DELTA programme with the aim to facilitate international cooperation of support to 
applied research and experimental development through joint programmes with 
technological (and innovation) agencies in non-European countries. However, judging 
from the funding flows, the activity under these agreements has been limited so far. 
Except only of the GA CR and TA CR bilateral grants, calls organized under these 
agreements are not regular. Generally speaking, there is a very weak link between these 
bilateral programmes on one hand and the European programs on the other hand.  
Bilateral agreements under GA CR recognize the assessment of proposals conducted by 
the partner funding agency, hence the National Science Foundation of Korea, Ministry of 
Science and Technology of Taiwan; however, it is not obligatory that the evaluation 
conforms to international peer-review standards, although this is typically the case. 
DELTA programme of TA CR recognizes evaluations of the partner technology (or 
innovation) agency as the basis for national funding decisions. Again, it is not explicitly 
required in the background documentation that the evaluation process of the partner 
agency conforms to international peer-review standards.  
4.4 An open labour market for researchers.  
4.4.1 Introduction 
In 2013, there were about 43 thousands researchers (full-time equivalent), of which 
nearly half were based in the business sector, a third in the higher education sector and 
slightly less than a fifth in the government sector. In terms of intensity, there were 
3,300 researchers per million people, which means close to the EU28 average but 
roughly half of the level maintained in top performing countries. The number of 
researchers roughly doubled during the ten-year period between 2004 and 2013, 
whereas it remained roughly stable during the main crisis period of 2008-2010 and even 
increased by about 17% over the recent period of 2010-2013; hence researcher 
workforce is steadily expanding (Eurostat, 2014).  
Labour market for researchers is characterized by high institutional autonomy. However, 
the approach to research human resource management is unsystematic in most public 
institutions. Human resources management practices in the public sector need to be 
modernised in order to reduce the widespread in-breeding, make career progression 
paths more transparent and intensify competition for posts. As shown by National 
Training Fund (2012), opportunities for early career researchers are weak, post-doc 
funding remains limited and especially in the university sector often not allocated on 
competitive basis, which reinforces in-breeding. Arnold (2011) reported that 
management of research groups is underdeveloped, the groups tend to be very small, 
locked into existing research trajectories and lacking interdisciplinarity, there is little use 
of career development plans and mobility among researchers is poor and there is a 
considerable scope for making better use of research internationalization. Much remains 
to be done in improving the labour market for researchers, such as reducing the in-
breeding problem, stimulating both horizontal and vertical mobility, making research 
careers more attractive for young people and increasing internalization in the public 
setor.  
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4.4.2 Open, transparent and merit-based recruitment of researchers 
General conditions of employment and the role of the state administration (especially the 
Ministry of Labour and Social Affairs) are regulated by the Labour Code (Act no. 
262/2006 Coll.) and the Act on Employment (Act. no. 435/2004 Coll.), if not stipulated 
by a special regulation. Most public research institutions conduct their activities in accord 
with the Act on Public Research Institutions (Act no. 341/2005 Coll.). For higher 
education institutions the main human resources issues are defined by the Tertiary 
Education Act (Act No. 111/1998 Coll.), which has been amended seventeen times and a 
novelization of which is in the pipeline, sets rules for the operation of higher education 
institutions, including the appointment of professors and docents.  
Nevertheless, the system is based on a high level of institutional autonomy. Research 
institutions have extensive self-governing rights and decision-making powers which have 
been further decentralized to the faculty and departmental level. Research institutions 
employ individual academics in a market driven decentralized system; the recruitment 
process is an internal affair of every institute. Hence, it is hard to assess policy-
measures that define the way researcher’s recruitment is carried out. 
Likewise, career development is a matter for internal institutional regulations in higher 
educational institutions. The Higher Education Act gives the task of appointing professors 
and obtaining venium docendi (habilitation) to the Scientific Board of the higher 
education institution. Professors are appointed by the President of the Czech Republic on 
the recommendation of the higher education institution’s council, submitted through the 
MEYS. Academic careers are hierarchical and consecutive and the academic titles have 
lifelong and countrywide validity, even though the underlying conditions vary by 
institution.  
The legislation rules provide an open access for foreign researchers to be employed at 
academic positions, especially in case of EU citizens. There are also measures simplifying 
inward mobility of researchers from the non-EU countries, such as the Scientific Visa 
Package. Inward flows of researchers are supported also by the EURAXESS network 
funded by the MEYS, which provides information support to incoming researchers. 
Attracting talented doctoral students from abroad is high on the agenda on some 
research institutes, albeit the achievement of this goal is rather difficult because of low 
financial support available (through there is the Fellowship J. E. Purkyně awarded at the 
CAS). A programme called NÁVRAT, i.e. “return" in English, administered by the MEYS is 
aimed to improve conditions for re-integration of top researchers coming back from 
abroad. Only a small number, not more than several dozens, of researchers have been 
supported by these programmes so far.  
Yet the academic labour market is quite internally oriented. As argued by Arnold (2011), 
there is a considerable scope for making better use of research internationalization in the 
public sector, the limited extend of which is in a sharp contrast to the pivotal role of 
foreign affiliates in the business sector. Only less than 10% of researchers are foreign, 
and half of those are Slovaks, which is very small proportion by international standards. 
An explicit internationalization strategy of the public research system is lacking. There is 
a very low horizontal mobility of academic staff leading to a clear pattern of inbreeding 
and limited competition for posts. Opportunities for early career researchers are weak, 
post-doc funding remains limited and often not allocated on competitive basis. 
None of the Czech institutions or organisations have received the Commission 
acknowledgement for progress in the context of the HR Strategy so far, i.e. there is no 
HRS4R acknowledged organisation with the so-called "HR Excellence in Research" badge. 
Three institutions, namely the CAS, Charles University in Prague and CEITEC - Central 
European Institute of Technology, have endorsed the Charter & Code, so the underlying 
principles have been transposed at national level by individual institutions, most notably 
in the sector of public research institutes.   
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In contrast, with the major exception of Charles University, there is generally little 
awareness and support of the principles in the higher education sector. So far national 
authorities have not encouraged public funded institutions to adhere to the Charter & 
Code. 
Apart from several smaller initiatives, the most prominent measure to increase the 
attractiveness of research careers is the Česká hlava (Czech Mind) project which awards 
an annual prize to distinguished Czech scientists. Recently this award has been extended 
for talented secondary students. Series of projects supported by the EU Structural Funds 
entitled Otevřena věda I, II, III and IV (Open Science) and Otevřená věda regionům 
(Open Science for Regions) have been organized by the CAS since; the projects were 
targeted at secondary school teachers and assisted them in directing students to 
research careers. In addition, activities aimed at increasing the attractiveness of 
research careers and popularising research include science and technology popularisation 
courses under the OP EC and development of science learning centres under the OP RDI.  
Unfortunately, reform of the labour market for researchers that was in preparation for 
three years largely ended up in doldrums. The higher education reform initially involved 
bold plans for modernization of conditions for human resources development. The reform 
was supposed to be implemented already but the drafting process has been derailed due 
to instability of the government and disagreements among the stakeholders The push for 
enacting a new law has been first relegated to an amendment that has been delayed by 
the collapse of the centre-right government in mid-2013 and then watered down 
significantly. The amendment is a compromise with the existing establishment that falls 
short of expectations if compared to the ambitious aims of the reform agenda. The main 
merit of the new regulation is in changes of the system for accreditation of teaching 
programmes in the higher education sector, however, it has not alteredthe current 
system of recruitment, hence not tackling the problem of inbreeding.    
4.4.3 Access to and portability of grants 
Overall, public research funders, such as GA CR and TA CR, support almost exclusively 
resident researchers, with the exception of special programmes and funding based on 
agreement for international research cooperation, which is however fairly limited. 
Funding for non-residents is generally not possible, unless they become residents for the 
purpose of conducting the research project. Language barriers for participation of foreign 
researchers are important; the main exception represents the grant programmes of GA 
CR and MEYS´s funding instrument  for large infrastructures for research, experimental 
development and innovation that require applications exclusively in English.  
National research funding programmes do not allow transferability of a grant to another 
country, thus research projects funded by national research programmes must be 
performed in the Czech Republic. An entity from other EU country may participate in a 
public R&D tender provided that such participant does not apply for support from the 
public funds of the Czech Republic. Hence, reciprocity is required in any international 
partnership..  
4.4.4 Doctoral training 
Universities are fairly autonomous in the way they develop doctoral training, which 
makes it extremely difficult to derive general conclusion on the degree to which the 
Principles for Innovative Doctoral Training are taken into account. Generally speaking, 
there are very large differences in this respect. Standardisation of PhD programmes is 
being currently tackled within the reform of tertiary education based on the debate 
corresponding to challenges identified in the White Paper on Tertiary Education (adopted 
by the government already in 2009). However, the policy does not refer nor takes into 
account the Principles for Innovative Doctoral Training so far, i.e. there is no support 
that specifically promotes the setting up and running of innovative doctoral training 
programmes.  
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4.4.5 Gender equality and gender mainstreaming in research 
Overall, gender situation in research is unsatisfactory (NKC – ženy a věda, 2015). The 
share of female researchers (full-time equivalent) is very low, only 24% in FTE in 2014 
and decreasing in recent years, which is far below the EU28 average. The share of 
female reseachers is far lower in the business sector with 15% only than in the higher 
education sector with 32% and the government sector with 36% (CZSO, 2015a).  
Nevertheless, gender equality issues are almost entirely ignored in research policy, the 
testimony to which is the fact that there is very little, if anything, on this topic in the key 
strategic documents, there are no formal regulations addressing gender imbalances in 
decision making processes, there are no public sector funding measures targeting female 
researchers in place.  
General legislation guides the behaviour of funders and employers on matters of non-
discrimination and equal opportunities (the Act No. 262/2006, Coll. on labour code, the 
Act No. 435/2004 Coll. on employment and the Act No. 198/2009, Coll. on 
antidiscrimination). Hence, there are hard laws on treating job candidates and 
employees equally as regards their recruitment, working conditions, remuneration and 
professional development. Also the general laws require that employers do not enquire 
about arguably irrelevant matters that might bias their decision (such as questions about 
pregnancy, etc.). 
The Czech Labour Code guarantees to female employees restoration to the same position 
after a maternity leave. However, an extension of the contract due to maternity leave in 
the case that an employee works in a fixed-term contract is not guaranteed by the law. 
The employee only has right to receive financial aid for the protective period of 180 days 
after the termination of the contract. Such conditions may be a barrier for female 
researchers’ career considering the fact that work contracts in research organizations are 
often on the fixed-term basis.  
In government proceedings (or law), the so-called "Jednací řád vlády", there is 
requirement to assess gender impact of every government resolution, i.e. there must be 
an appendix evaluating gender impact. However, this has a limited impact on gender 
equality in the RDI policy, as the CRDI – formally only an advisory body of the 
government - is not obliged to follow this rule, hence the governance system ensuring 
that gender issues are considered is bypassed, because gender equality is rarely 
considered when the actual decisions are made in the council (before submitting the 
results to the government for a formal approval).   
In 2009,  the Working group for equal opportunities for women and men, including a 
committee for science, has been launched at the MEYS, the purpose of which is to 
formulate priorities of the ministry on gender equality. In 2001, furthermore, as the 
follow up on the establishment of the Helsinki Group, the Working group for women in 
science in the Czech Republic started to operate in the MEYS. However, both of the 
working groups have limited powers, operate at the lowest level of hierarchy and appear 
to have a rather small impact on decision making.  
In 2001, the government adopted Resolution No. 1033 on the Council of the Government 
for Equal Opportunities for Women and Men. The Council is a permanent advisory board 
of the government for equal opportunities policies. At the meeting on the 23rd February 
2010, the Council of the Government for Equal Opportunities for Women and Men 
addressed for the first time the problem of gender equality in science, and drafted a 
suggestion to the government regarding fair representation in expert and advisory 
bodies and grant competitions. However, while acknowledging this suggestion, the 
government did not initiate any action in this respect. Furthermore, there are ministerial 
gender focal points. Since 2001 ministries are required to create a systemic job to take 
care of the equal opportunities agenda. However, the gender focal points do not have 
any powers.  
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Female researchers have the possibility to interrupt or postpone solving a postdoctoral or 
junior grant of GA CR due to maternity leave for exactly one year only; they are obliged 
to inform the agency about their pregnancy when they become aware of it and the leave 
can start only on the 1tst of January or the 1st of July. Other grant provides still do not 
allow female researchers to interrupt of postpone research grants due to maternity 
leave. In April 2012, the GA CR maternity leave regulation was challenged by a formal 
complaint to the Public Defender of Rights, who in January 2013 confirmed its 
discriminatory nature and recommended GA CR to adjust the rules accordingly. GA CR 
agreed to relax the rules. However, only minor changes in the specification of the junior 
grant recipients have been implemented so far. 
The main agent promoting cultural change in women in science is National Contact 
Centre for Women and Science. Established in 2001, the centre contributes to building 
gender equality in science and research by stimulating debates and petition for measures 
and steps to eliminate discrimination and gender inequalities. Moreover, they urge action 
from responsible institutions, offer solutions to improve the professional advancement of 
women, i.e. lobby for gender equality. Also the team carries out analyses that address 
the asymmetrical distribution of power between men and women in science in order to 
raise awareness about gender issues and give visibility to women researchers and their 
work. The centre is a project of the Institute of Sociology of the CAS.  
Milada Paulová Award is organized jointly by MEYS and National Contact Centre for 
Women and Science for lifelong achievement of female researchers to Czech science 
since 2009. The award aims to publicly and financially appreciate research achievements 
of prominent Czech women researchers, who provide role models and inspires women 
researchers and students at the beginning of their research careers. The winner receives 
an award of 150,000 CZK.  L’ORÉAL Scholarship Czech Republic for Women in Science is 
awarded by L’ORÉAL in cooperation with CAS and UNESCO for young female scientists in 
the field of natural sciences (no more than 35 years old) since 2007. The winner receives 
a fellowship grant of 250,000 CZK. 
4.5 Optimal circulation and Open Access to scientific knowledge  
4.5.1 e-Infrastructures and researchers electronic identity 
The keystone of the Czech e-infrastructure for research is CESNET (Czech Education and 
Scientific NETwork); national partner of GÉANT and EGI.eu and the coordinator of NGI 
(National Grid Infrastructure). CESNET, association of legal entities, was established in 
1996 as a joint venture of universities and the CAS. Its main goals are: i) Operation and 
development of the Czech NREN; ii) Research and development of advanced network 
technologies and applications; and iii) Broadening of the public knowledge about the 
advanced networking topics. CESNET participates in a number of international projects 
(DANTE shareholder, TERENA member, Internet2 partner, European GN2 project and 
GLIF participant).  
CESNET is an integral part of the Roadmap for Large Research, Development and 
Innovation Infrastructures in the Czech Republic, updated in May 2015 (MEYS 2015a). 
The CESNET is developing this infrastructure with support from public budgets under two 
major RIs projects, namely CESNET Large Infrastructure and Extension of the National 
R&D Information Infrastructure in Regions (eIGeR). The reconstruction of the CESNET2 
backbone network started in 2011; it forms the necessary foundation for the other 
components of the national information e-infrastructure. 
IT4Innovations is a unique project (integrated in the ESFRI Roadmap) of a national 
Centre of Excellence in the field of information technologies. The centre enables the 
concentration of a wide range of scientific disciplines relating to information technologies 
and thus achieves development in respective spheres. Part of the project is acquisition of 
a high-performance supercomputer which has been put into operation in 2014 and which 
ranks among the top 100 most powerful supercomputers in the world. IT4Innovations is 
the national partner of PRACE (Partnership for Advanced Computing in Europe).  
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EDUROAM infrastructure has been implemented by CESNET. The purpose of the 
eduroam.cz project is to support and spread IP mobility and roaming within the Czech 
NREN. CESNET task is to in coordinate and propagate eduroam ideas at national level, 
supporting academic organisations interested in cooperation with eduroam.cz project. 
Moreover, CESNET operates the Czech academic identity federation eduID.cz project. 
The eduID.cz federation is based on the Shibboleth project developed by Internet2 and 
is a member of eduGAIN and participates in REFEDS. CERIT Scientific Cloud offers 
storage and computing resources and related services, including support for their 
experimental use. 
4.5.2 Open Access to publications and data 
Generally, there is growing consensus in the scientific community to allow open access 
to publications whenever possible, but the concern is about the funding for such 
arrangements. Hence, open access to both scientific publications and data for research 
purposes hinges on poorly developed infrastructure and institutional framework. The 
awareness of open access movement ideas is concentrated among library staff, but there 
are efforts to raise the awareness, such as the portals www.openaccess.cz and 
www.dspace.cz, which promote the open access ideas among researchers. Policies with 
regards to access to scientific publications are fragmented; the deals are negotiated 
separately by the individual research organizations. Research grants rarely consider 
costs of gold publishing and the funding agencied do not stimulate the researchers to do 
so. National open access repository does not exist. 
Archambault, E., et al. (2014) reported that during the period 2008-2013 the percentage 
of peer-reviewed articles published in open access journals was 6.8% compared to the 
EU28 average of 9.4% in the green category, i.e. self-archiving of final peer-reviewed 
manuscripts in institutional or subject repositories and 9.6% compared to the EU28 
average of 8.6% in the gold category, i.e. pay to publish in open access, respectively. 
Hence, there is a noticeable room for improvement in using the green open access, but 
there is already a sizeable potential for leveraging the possibility of gold open access, 
which however makes a difference only if the author actually pays for it. Unfortunately, 
no data is available on the latter.  
According to OpenAIRE, there is no official government mandate to deposit research 
output arising from grants, no research funding agency requires that, nor exists any 
university which mandates to deposit published journal articles in its open repository. 
OpenAIRE gives a list of 11 open access repositories and 4 research data repositories 
scattered in libraries of various research organisations and universities. Although the 
Berlin Declaration has been signed by eight organisations, including the GA CR, CAS and 
Masaryk University, and there is a growing number of open access journals published by 
the Czech research organisations, the adoption of open access to scientific publications 
remains in the early phase. 
The Update of the National Research, Development and Innovation Policy 2009-2015 
with an outlook to 2020 admits that policies with regards to access to scientific 
publications, i.e. journal subscriptions, are fragmented; the deals are negotiated 
separately by the CAS and universities, which leads to inefficiencies, and that there is a 
need for forming consortium at the national level for this purpose (CRDI, 2013a). It is 
concluded that “access to information infrastructure for the system of research, 
development and innovation is not provided in a satisfactory manner”. Admittedly, there 
is a looming deficit in this respect that represents a major challenge for policy. The CRDI 
at its 291st meeting in February 2014 approved a resolution on open access to publicly 
funded scientific publications that recommends to develop a national strategy of open 
access, intensify support to efforts of research organizations to facilitate open access and 
encourages research funding agencies to require open access.  Nevertheless, there are 
currently no measures or funding at the national level for promoting open access 
publishing.  
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The Czech Statistical Office (CZSO) provides confidential statistical data for scientific 
research purposes. Microdata can be provided only on the basis of a special contract, 
which stipulates conditions for the data confidentiality protection and the exact way of 
data use in accordance with the legislation. Data is provided in the form not allowing the 
direct identification of reporting units only to domestic and foreign legal entities the 
primary mission of which is scientific research. However, microdata is provided only from 
a handful of surveys, especially access to firm-level data is severely limited. In addition, 
there is no safe-room in the CZSO and on-line remote access to micro data for scientific 
purposes is not provided; each data release needs to be negotiated separately, which 
hinges merging of datasets, creating longitudinal panel data and hence undermines 
efforts to conduct research on the data systematically over long-term. 
The CRDI administers the Research and Development and Innovation Information 
System of the Czech Republic (ISVaV), a well-developed information system for a 
collection, processing, publication and utilisation of data about publicly funded research 
activities, projects and their outputs. Access to this information system is required to be 
open and available on-line by the law. The system consists of the following databases: 
1) Central register of R&D projects (CEP); 2) Central register of Institutional Research 
Plans (CEZ); 3) Information register on R&D results (RIV); 4) Central register of R&D 
Activities (CEA); and 5) Register of public R&D tenders (RES). Most of the datasets are 
updated quarterly and direct searching in the databases is possible through the user 
application. 
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5. Framework conditions for R&I and Science-Business 
cooperation 
5.1 General policy environment for business 
According to the index of the general policy environment for doing business by World 
Bank (2015), the Czech Republic is ranked on the 44th position in 2015 up from the 
47th spot in 2014 worldwide, 19th in the EU28 and 7th among the new EU member 
countries; just short of Belgium but ahead of Romania, Slovenia, Hungary, Italy or 
Greece. The main strenghts are in the components for registering property, enforcing 
contracts, resolving insolvency and getting credit; the latter also registered the largest 
year-on-year improvement. The main weaknesses are highlighted in the realm of 
starting a business, dealing with construction permits, getting electricity, protecting 
minority investors and paying taxes. The results are remarkably uneven across the 
individual components of the index, ranging from the 23th to 139th position, which 
indicates highly uneven progress in improving the general business environment.  
In 2008, a comprehensible reform of the research, development and innovation system 
was launched. The reform is outlined in the National RDI Policy of the Czech Republic 
2009–2015 (CRDI, 2009) and the Update of the National Research, Development and 
Innovation Policy 2009-2015 with an outlook to 2020 (CRDI, 2013a). The reform 
profoundly changed the governance of system, established the TA CR as the dominant 
supporter of applied research and brought to the attention of policy-makers the role of 
innovation and private-public research linkages for national competitiveness. 
Business investment in research and innovation is not only supported by direct subsidies 
anymore, which used to be the dominant policy measure, but by much broader portfolio 
of instruments, including R&D tax credits both for internal activities as well as purchase 
of external inputs from research organizations, support programmers for joints research 
projects between the public and private sectors, regional innovation voucher 
programmes. Nevertheless, RDI policies continue to neglect the potential of using 
demand side instruments and continue to be deeply rooted in the linear model of 
innovation. Coordination between the various policy instruments, including within the 
supply side, is underdeveloped and their synergies remain unexploited. Public 
procurement is not seen as an instrument to promote innovation.  
According to the Research and Innovation Performance Country Profile by the the 
European Commission (2014c),  structure of the economy is generally favourable, the 
high- and medium-high-technology sectors are relatively large, but business R&D 
investment is relatively low, despite a positive trend, thus the innovation performance is 
deemed to remain below its potential. Another evergreen weakness that was highlighted 
refers to the limited cooperation between the science and business sectors. The key 
science and technological strengths were identified in the fields of automobiles, other 
transport, construction, materials, energy and environment.  
5.2 Young innovative companies and start-ups  
A major weakness of the public research sector has traditionally been limited knowledge 
transfer from science to practical applications, poor commercialization of scientific 
outputs and underdeveloped entrepreneurship culture among scientists. Professors 
rarely get involved in spin-offs. No official data is available on the number of start-ups 
involving scientists, which is at least partly attributable to the fact that anecdotal 
evidence suggests that they are extremely rare. The evaluation system, including the 
allocation of institutional funding at the organization level and career progression paths 
at the individual level, heavily relies on indicators of scientific output and does not 
motivate scientists to get involved in commercialization activities. The only exception is 
Pillar III. of Metodika 2013 (for more details see Section 3.4.2.), however, only a 
relatively small proportion of the evaluation points (and hence funding) is awarded to 
these activities.  
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Public R&I support programmes have been seldom focused on funding innovative start-
ups so far. TA CR has been established in 2009 as the dominant supporter of applied 
research and innovation and launched a portfolio of new programmes; however, none of 
its programmes has been devoted to supporting young innovative companies. Only 
several smaller programmes of the OP EI under the MIT, most prominently Start, helped 
start-ups to overcome the limited availability of external funding, while the Cooperation 
programme supports the establishment of technology platforms and clusters. Regional 
governments are increasingly implementing innovation voucher programmes, including 
in South Moravia, Moravia-Silesia and Prague; however, the latter has prematurely 
terminated the programme and in any case the regional voucher funding is rather 
limited.   
Nevertheless, there have been bottom-up efforts to promote university spin-offs at the 
level of individual institutions that deserve to be mentioned. Several business incubators 
for start-up companies of university students have been opened in the higher education 
sector, for example, InovaJET at the Czech Technical University in Prague has already 
supported about 80 projects since 2010 and xPort at the University of Economics in 
Prague and Point One at the Czech University of Life Sciences Prague have been just 
launched.  In addition, the CAS has published, as a part of its new Strategy AV21 
released in December 2014, the overview of the so-called “application laboratories” 
(CAS, 2014), which provides a commercial presentation of 24 facilities with the aim 
promote linkages to the industry, technology transfer and harness the potential fo 
contractual research. Yet the results of this measure remain to be seen. 
5.3 Entrepreneurship skills and STEM policy 
Labour market for researchers continues to suffer from an insufficient supply of experts 
with an appropriate mix of skills, especially in science, technology and engineering. 
According to the data from the Czech Statistical Office (2015a), the number of PhD 
graduates has stagnated in recent years and there is a long-term tendency for the 
proportion of science and technology tertiary students to decrease in comparison to 
those of social science and humanities, however, policies to boost the supply of 
(post)graduates in science and technology are lacking. The assessment of MIT (2011b) 
concluded that because the reform of tertiary education remains uncompleted, there has 
been an unchecked expansion of university graduates, the quality of which is however 
hard to judge. Education and training curricula in higher education are heavily 
traditional, generally not equipping people with critical thinking, problem solving, 
teamwork and communication skills. Entrepreneurship educational programmes are 
missing in higher education. Projections of the future development of the human 
resource base in research are lacking. 
5.4 Access to finance 
The European Commission (2015a) vindicates that the utilisation of venture capital to 
support innovative businesses and spin-off firms is one of the lowest among European 
countries and that the limited access to external sources of finance for innovation is 
perhaps the single most important obstacle to the improvement of the innovative 
performances. Venture capital investment dropped to less than €1m in 2012 and 2013 
and was limited to €6m in 2014. Only several companies receive venture capital funding 
each year (Eurostat, 2015). Statistics on crowdfunding and business angels is not 
available, at least not reliable data from official sources, probably because it also very 
rare.  Unfortunately, a lack of experience among potential clients and rather traditional 
entrepreneurial culture do not form an environment favourable to venture capital 
expansion.   
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Public measures to support venture capital are missing. Since 2011 the MIT has 
attempted to establish a public-private seed fund to kick-start the market. A budget of 
€53m funded from the OP EI was earmarked for the fund. The seed fund was ready to 
start operation; however, in 2013 the launch of the project has been derailed by the 
ruling of the Office for the Protection of Competition due to dispute over the tender for 
the fund’s custodian and in 2014 the project was eventually terminated (CzechTrade, 
2014). Nevertheless, MIT re-launched this effort under the OP EIC in the new 
programming period, as the results of which in October 2015 the government gave a 
green light for the the establishment of a pilot National Innovation Fund (NIF) to provide 
jointly with private investors capital to innovative SMEs that have difficulty to access 
credit funding 
INOSTART programme, a joint effort of the main commercial bank Česká spořitelna and 
the MIT launched in 2014 that is backed by the Partnership Fund of Czech-Swiss 
Cooperation and the state-owned Czech-Moravian Guarantee and Development Bank, 
remains the only major instrument that supports innovative business start-ups in terms 
of loan guarantees for innovative projects and consultancy services. 
5.5 R&D related FDI 
CzechInvest, an agency of MIT, is responsible for attracting R&D related FDI. The main 
policy instrument is the general investment incentive programme; however, there are no 
incentives specifically devoted to FDI in R&D in place. As far as support to FDI in R&D is 
concerned, CzechInvest mainly engages is reducing information asymmetries by 
organizing matchmaking events between foreign investors and indigenous actors, 
including from the public research sector. Hence, all of the available direct and indirect 
R&I support instruments are available both for domestic and foreign firms under equal 
terms.  
Official statistics of R&D intensive FDI investments does not exist. Yet the Czech 
economy apparently managed to attract sizeable amount of R&D related FDI, the 
testimony to which is the fact that most of the largest R&D spenders are well-known to 
be foreign affiliates (for more details see Section 1.2.3), as also vindicated by the tripling 
of R&D investment expenditure, i.e. the part of R&D expenditure that refers to 
investment in tangible and intangible assets excluding operating R&D costs, of foreign 
affiliates from €57m (CZK 1.56b) in 2010 to €105m (CZK 2.90b) in 2012 and to €172m 
(CZK 4.74b) in 2015 (CZSO, 2015a). 
5.6 Knowledge markets 
Formal methods of intellectual property rights (IPRs) protection, in particular patents 
and their licensing, remain underutilized, as clearly shown by European Commission 
(2015a), in spite of the continuous effort to improve the use of public R&D outputs in 
innovation processes and despite the fact that state of the art IPRs legislation is in place. 
Too few experts and little experience can be found in this domain, especially in the public 
sector, except only perhaps of a few exceptions under the umbrella of CAS, such as the 
Institute of Organic Chemistry and Biochemistry (IOCB), that prove the rule. Poor 
commercialisation of R&D outcomes in general requires systematic attention as well as 
support to research excellence to produce high valuable research outcomes being worth 
of patenting costs. 
While statistics on applications to national patent office are not always comparable 
across countries, they can provide some indication of technological development 
activities that are not captured by EPO/PCT data. In the Czech Republic, according to the 
data by INCENTIM KU Leuven and Bocconi University (2014), 1.3 thousand patent 
applications were made at the EPO, 1.5 thousand patent applicants took the PCT route 
and the Industrial Property Office of the Czech Republic received about 8 thousand 
applications in the period 2000-2010; these figures are based on fractional counting. In 
terms of patenting per capita, however, the Czech Republic remains far below advanced 
countries.   
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According to the survey of licenses by CZSO (2015a), between 2008 and 2014 the 
number of organizations with licensed patents increased from 42 to 67 and the number 
of licensing agreements on patents increased from 253 to 402, respectively, hence there 
is a positive trend, despite the low levels. In 2014, public research organizations and 
universities had a share of 29% in the number of licensed patents but accounted for 
89% of €99m income from licence fees from patents, however, a lion share of the latter 
can be traced back to income of a single organization, namely the IOCB, from licencing 
of patents for antiretroviral drugs developed by professor Antonín Holý to U.S. 
pharmaceutical companies. Hence,  this is not a systemic feature. 
As far as the policy in the area of IPRs is concerned, the owner of invention developed in 
the public sector, i.e. supported by institutional or project funding, is nominally the 
university or the government research institute and its utilization needs to be specified 
by their internal regulations. However, the oversight and enforcement of this rule is 
weak and there is a large scope for opportunistic behaviour of researchers when deciding 
on who owns IPRs on knowledge generated within public support. In practice, 
commercialization of inventions originating from the public sector follows both formal 
and informal rules established at the level of individual organizations, much depends on 
governance of the particular workplace, and hence there are wide differences in this 
respect throughout the system. National strategy of IPRs utilization is lacking.  
5.7 Public-private cooperation and knowledge transfer 
5.7.1 Indicators  
Funding: BES-funded public R&D 
 
Figure 17 BES-funded public R&D in the CZECH REPUBLIC as % of GERD (in €MLN) and 
% of GDP 
 
The level of the Czech business enterprise (BES)-funded public R&D expenditure as a 
percentage of GERD was decreasing in the period 2002-2009 to start increasing in the 
last years (2012-2014). The same pattern is visible when we expressed it as % of GPD, 
in this case the growth of this indicator commenced already in the 2012. The amount of 
the expenditure however is so insignificant (oscillating between €23m and €29m) that 
the analysis of the trends would not bring many insights. 
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Figure 18 BES-funded public R&D as % of GERD and as % of GDP in 2013 in Member 
States13 
 
The two charts in Figure 18 show the values of BES-funded public R&D in all EU-28 as 
percentages of GERD and GDP respectively.  
The Czech Republic's levels are far below the EU-28 average for both indicators.  
The low level of the BES-funded public R&D indicator can be explained by the structure 
of the R&D intensive sector in the Czech Republic: An important part of the Czech BERD 
is performed by multinational companies that tend to carry out their R&D in-house. 
 
Funding: Structural funds devoted to knowledge transfer 
 
Figure 19 Structural Funds for core R&D activities 2000-2006, 2007-2013 and 2014-
202014. We use the categories: 182 (2000-2006)15, 03 and 04 (2007-2013)16 and 062 
(2014-2020) as proxies for KT activities17.  
                                          
13 2013 was chosen as the latest data series providing a full comparison within EU-28.  
14 Figure 19 provides the Structural Funds allocated to the Czech Republic for each of the above 
R&D categories. The red bars show the categories used as proxies for KT. Please note that the 
figures refer to EU funds and they do not include the part co-funded by the Member State. 
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The Czech Republic has allocated only 2.7% of its structural funds to core R&D activities 
to "Technology transfer and university-enterprise cooperation primarily benefiting SMEs" 
(compared to 63.9% for 2000-2006 and 23% in the 2007-2013 programming period). It 
is significantly lower than the EU average of 15.7% (the EU average was 26.1% for 
2000-2006 and 30.1% for 2007-2013) and much lower than in the last two 
programming periods. The Czech Republic still invests a very important part of the 
structural funds in the public research infrastructures and public research centres 
activities.    
                                                                                                                                 
15 The categories for 2000-2006 include: 18. Research, technological development and innovation 
(RTDI); 181. Research projects based in universities and research institutes; 182. Innovation and 
technology transfers, establishment of networks and partnerships between business and/or 
research institutes; 183. RTDI infrastructures; 184. Training for researchers. 
16  The categories for 2007-2013 include: 01. R&TD activities in research centres; 02. R&TD 
infrastructure and centres of competence in specific technology; 03. Technology transfer and 
improvement of cooperation networks; 04. Assistance to R&TD particular in SMEs; 74. Developing 
human potential in the field of research and innovation. 
17  The categories for 2007-2013 include: 01. R&TD activities in research centres; 02. R&TD 
infrastructure and centres of competence in specific technology; 03. Technology transfer and 
improvement of cooperation networks; 04. Assistance to R&TD particular in SMEs; 74. Developing 
human potential in the field of research and innovation. 
17  The categories for 2014-2020 include: 002. Research and Innovation processes in large 
enterprises; 056. Investment in infrastructure, capacities and equipment in SMEs directly linked to 
Research and Innovation activities; 057. Investment in infrastructure, capacities and equipment in 
large companies directly linked to Research and Innovation activities; 058. Research and 
Innovation infrastructure (public); 059. Research and Innovation infrastructure (private, including 
science parks); 060. Research and Innovation activities in public research centres and centres of 
competence including networking; 061. Research and Innovation activities in private research 
centres including networking; 062. Technology transfer and university-enterprise cooperation 
primarily benefiting SMEs; 063. Cluster support and business networks primarily benefiting SMEs; 
064. Research and Innovation processes in SMEs (including voucher schemes, process, design, 
service and social innovation); 065. Research and Innovation infrastructure, processes, technology 
transfer and cooperation of enterprises focusing on the low carbon economy and on resilience to 
climate change. 
 67 
 
Cooperation: Share of innovative companies cooperating with academia 
 
Figure 20 CIS survey 2012 – share of enterprises cooperating with academia 
 
Figure 20 depicts the level of cooperation activities of innovative companies in the EU-
28, according to the CIS 2012. The percentage of "enterprises engaged in any type of 
co-operation" (green dot) is in the Czech Republic relatively high - 37.3%, a bit higher 
than the EU-28 average of 31.3%. The percentage of enterprises involved in cooperation 
with universities or other HEIs (blue bar) is 15% compared to the EU-28 average of 
13%, whereas government, public or private research institutes (red bar) is 6% 
compared to 8.9% of the EU-28 average.  
Cooperation: Technology Transfer Offices (TTOs offices), incubators and 
technological parks 
The Czech Republic has at least 10 Business and Technology Incubators18 (that can be 
part of larger science parks). There are 14 Science and Technology Parks19 accredited by 
the Czech Science and Technology Park Association and another 30 are in a process of 
accreditation as well as 7 parks under preparation. There are at least 20 TTOs offices, 10 
are within public universities, two within research institutions, five established by 
municipalities, one by a private research institute and two established jointly by 
universities and research institutes20. The Academy of Sciences also has a central office 
for patents and licensing. TTOs have been mainly financed from structural funds in the 
last programming period (priority Axis 3 “Commercialisation and popularisation of R&D 
of the OP).  
Establishing technology transfer points and offices in research institutions as a way to 
use research results is one of the activities eligible within the Priority Axis 3 
“Commercialisation and popularisation of R&D “ of the OP RDI administered by the 
MEYS. The first technology transfer offices were supported from this programme at the 
beginning of 2012.  
                                          
18 http://www.czechinvest.org/en/incubators  
19 http://www.svtp.cz/en/catalog/  
20 http://knowledge-transfer-study.eu/fileadmin/KTS/workshop/European/KTS_WS_CZ-SK-HU-
SI_2012-04-25_Presentation_M.Pazour.pdf  
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Cooperation: Share of public-private co-publications 
 
Figure 21 Co-publications by field 2003-2013 in the Czech Republic. Scopus database 
 
The Figure 21 shows the 2003-2013 average percentage of academia-industry co-
publications by field in the Czech Republic compared to the European average. The total 
share of co-publications, displayed by the red "overall" bar on the left of the chart, is 
1.1%, half of the EU-28 average of 2.2%. Excluding multidisciplinary publications and 
nursing, the domains recording the highest share of co-publications are: energy, physics 
and astronomy, and pharmacology, toxicology and pharmaceutics. 
Scopus data indicates that with 17.5 co-publications per million population, the Czech 
Republics is below the EU-28 average of 29.0 and performing better than neighbouring 
countries with 9.8 for Poland and 12.8 for Hungary. Still, the Czech Republic is situated 
very far from the Innovation Leader countries (Denmark stands at 182.1, Finland at 
155.0, Germany at 57.8 and Sweden at 113.3). 
Cooperation: Patenting activity of public research organisations and 
universities together with licensing income 
The patenting activity of public research organisations has grown in the recent years 
(from 108 patents granted by the Czech Industrial Property Office in 2008 to 221 in 
2014) 21 . The Knowledge Transfer Study also locates the Czech Republic above the 
European average of 4.5 with 7.8 granted patents per 1 000 research staff. 
The growth in patenting activity has not been matched with the increase of licensing 
agreements which may suggest that most of the public sector patents are unused and 
were prompted by the methodology of the evaluation of the public research results. In 
2014, 30% of licensors of patents and utility models come from public universities and 
                                          
21 https://www.czso.cz/csu/czso/22-science-and-research  
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PROs (25 in absolute numbers, including 14 new licensors which is a slight decrease 
compared to 2013). The Knowledge Transfer Study reports 1.6 licensing agreements per 
1 000 research staff compared with the European average of 6.5. 
The PROs licenses generate an impressive rate of 84% of the total licensing income 
which amounts to 2.467bn CZK in licensing fees. Yet only 1.5m CZK in 2014 was 
generated by the new licences22. Nevertheless, the situation of the Czech Republic is 
particular. If one does not take into account the licensing revenue of the Institute of 
Organic Chemistry and Biochemistry AS CR, which generates a considerable income from 
patents for antiretroviral drugs, the licensing revenue is very low as confirmed by the 
low value of the new licenses (CDRI 2015).  
 
Table 5 Patent sales and utility model licenses by type of licensors in 201423 
1) Number of licensors with valid patent and/or utility model license agreement do not 
need to be equal to sum of licensors with valid patent license agreement and licensors 
with valid utility model license agreement because one licenser can have both valid 
patent license agreement and valid utility model license agreement 
Cooperation: Companies 
According to the KT study results, the Czech universities and public research institutes 
have 0.8 start-ups per 1 000 research staff compared to the European average of 1.7.   
                                          
22 http://www.czso.cz/csu/2014edicniplan.nsf/engp/213002-14, 
http://www.czso.cz/csu/2014edicniplan.nsf/p/213002-14  
23 Czech Statistical Office, Licences 2014. 
https://www.czso.cz/documents/10180/20555107/2130021503.pdf/e3790421-79a4-46ad-bbaf-
87da2261417c?version=1.0  
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Figure 22 Number of start-ups per 1000 research staff by country. Source: KT study 
2010-2012 
 
Cooperation: intersectoral mobility 
Private-public mobility of researchers appears to be weak. In 2012, about 7% of R&D 
employees in the business sector were doctorate holders (CZSO, 2014a), hence received 
research training in the university sector. Unfortunately, no direct data is available on 
the circulation between the private and public sectors, such as the share of researchers 
in public organisations with experience in the private sector and vice-versa. Other 
relevant information, including the share of professors whose primary occupation is in 
industry and the number of researchers benefiting from academia-industry exchange 
contracts, is probably not collected, because it is very close to zero. Also there is no 
official data on the number of invention disclosures, public-private research partnerships 
and start-ups stemming from public-private cooperation, because these events are fairly 
rare.  
5.7.2 Policy Measures 
“Cooperation and knowledge transfer between academia and industry” is one of four 
priority areas of the National Innovation Strategy of the Czech Republic (NIS) that has 
been produced jointly by the MIT and MEYS in line with recommendations of the 
Innovation Union strategy of the EU in 2011.  In April 2013, also the national research, 
development and innovation (RDI) policy for 2009-15 was updated and its stress on 
knowledge transfer and the innovative capacity of the business sector was reinforced.  
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The National RIS3 Strategy has been approved by the government and submitted to the 
European Commission in December 2014. The key enabling technologies have been 
specified as: i) Advanced materials; ii) Nanotechnology; iii) Micro- and nano-electronics; 
iv) Advanced production technologies; v) Photonics;  vi) Industrial biotechnology; vii) 
Knowledge for digital economy, cultural and creative industries; and viii) Social science 
knowledge base for non-technical innovation. Four national S3 platforms have been 
formed: i) Engineering; ii) Information and telecommunication services and software; iii) 
Transport equipment; and iv) Pharmaceuticals and life technologies; more are expected 
to be added through the entrepreneurial discovery over time.  
The projects run by the Technology Agency of the Czech Republic that are related to 
knowledge transfer include: 
The GAMA Programme supporting the preparation for subsequent commercialisation of 
R&D outputs. The main objective of the programme is to support and significantly 
streamline the transformation of R&D&I results achieved in research organizations 
and/or in collaboration between research organizations and enterprises into practical 
applications to enable their commercialisation and support their implementation. The 
total expenditure on the programme will be 2 770m CZK, of which 1 798m CZK 
covered from the state budget. It runs from 2014 till 2019. Awarded projects will have to 
bring at least one of following outputs: patents, technically realised results (prototypes, 
functional samples), pilot operations, verified technologies, software, results with legal 
protection (utility models, industrial designs). 
The DELTA programme aims at supporting collaboration in applied research and 
experimental development projects through joint projects of enterprises and research 
organizations with major foreign technological and innovation. It will run from 2014 till 
2019 with 1 039.2m CZK budget. The programme will be monitored by number of 
patents, utility models and industrial designs, functional prototypes and samples, 
number of certified methodologies and procedures, software and pilot operation, verified 
technologies. 
The recently launched EPSILON programme, a follow-up on ALFA (see below), aims at 
supporting applied research and experimental development with a high potential for 
rapid application in innovations in three priority areas of competitive knowledge-based 
economy, sustainability of energy and material resources and environment for quality of 
life with a budget allocation of €373m over 2015-2025. 
The ALFA programme supported applied research and experimental development 
especially in the field of advanced technologies, materials and systems, energy resources 
and the protection and creation of the environment and the sustainable development of 
transport. The programme placed emphasis on strengthening public-private partnerships 
in research, development and innovation and research, development and innovation 
projects requiring rigorous co-financing from private sources. It had a budget 7.5bn CZK 
(65% of public financing, the rest funded from private sources) for 2011-2016. 
The Competence Centre programme supports the establishment and operation of centres 
for research, development and innovation in advanced fields with high application and 
innovative potential. The centres will create the conditions for the development of long-
term cooperation in research, development and innovation between the public and 
private sectors. The duration of the programme is from 2012 to 2019 with three-stage 
public tenders (2011, 2013 and 2015) with a budget of 6bn CZK (70% publicly funded, 
the other 30% from private sources).  
The Ministry of Industry and Trade manages the TIP programme 2009-2017 (12.4bn 
CZK), ALFA predecessor. Further to that the Ministry introduced in 2015 a new 
programme TRIO for support of business R&I and public-private research collaboration in 
key enabling technologies with a budget of €134m over 2016-2021, which largely 
overlaps with the purpose of the TA CR’s program EPSILON.   
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CzechInvest (MIT executive agency) manages two programmes Innovation which targets 
knowledge transfer and Prosperity which supports the creation of science and 
technological parks, TTOs and business angels networks.  
All but one Czech regions run innovation vouchers programmes (first introduced by the 
South Moravian Innovation Centre in 2009). South Moravian Region offers a subsidy 
worth up to 6 000 Euro covering 75% of the supported project intended for a purchase 
of knowledge from one of regional research institutions. Still, the largest programme in 
the capital city of Prague had a budget of only €0.5m in 2014 and was discontinued in 
2015. Due to its success at regional level the innovation vouchers are to be continued in 
the new programming period. 
Finally, in 2014, the Czech government has extended the existing tax credits to external 
R&D services, i.e. contractual research purchased from research organizations. This 
change was aimed at stimulating industry-academia collaborations. The amendment was 
expected to bring a 60% increase of the intensity of contractual research in 2014 while 
the total estimated volume of newly claimed deductions from income tax pursuant to the 
amendment was put at 0.25 billion CZK in 201424.. The 2014 National Statistical Office 
data do not support this claim given a general decrease in theamount of tax relief in 
201425 (unfortunately there is no information about the new relief uptake). The intensity 
of contractual research has risen by less than 20% in 2014 (Eurostat 2015). 
Commercialization of know-how in the research organizations (Proof-of-concept 
programme) will be financed by OP EIC under NIF (along with venture capital 
programmes for start-ups) trough equity finance measures. 
The project EF-TRANS (Efficient Transfer of Research and Development Outputs in 
Production and their Subsequent Utilisation26) carried out in 2009-2013 was aimed at 
identifying barriers to knowledge transfer in the Czech Republic. The EF-TRANS project 
analysed the legal environment and the knowledge transfer situation in the Czech 
Republic and abroad. The main objectives of the EF-TRANS were: to improve the 
cooperation between research institutions and universities with industry in order to 
facilitate the commercialisation of R&D results; to enhance the utilisation and legal 
protection of intellectual property; and to motivate students, employees of universities 
and research institutions and to instruct them on which steps to take in this process. The 
project developed methodologies for the Czech PROs (on a commercialisation system, IP 
protection, cooperation with business, licenses use, company establishment, result 
evaluation, and entrepreneurship education) as well as a Guide for Commercialisation27. 
Policy measures supporting horizontal mobility such as traineeships or integration in the 
organization of industry-oriented PhD programmes are still missing however mentioned 
in the National Smart Specialisation Strategy. 
The Analysis of the State of Research, Development and Innovation in the Czech 
Republic and a Comparison with the Situation Abroad in 201428, an annual overview of 
the R&I system presented to the government in September 2015 refers to the low level 
of public-private collaboration and technology transfer and recommends deepening the 
support of public-private linkages that stimulate R&I efforts in the business sector.  
                                          
24 http://www.tacr.cz/index.php/en/14-novinky/356-income-tax-impetus-czech-research.html  The 
Czech Statistical Office should publish the new data on the indirect aid in April 2016. 
25 https://www.czso.cz/csu/czso/neprima-verejna-podpora-vyzkumu-a-vyvoje-v-ceske-republice-
2014  
26 http://eftrans.reformy-msmt.cz  
27 http://eftrans.reformy-msmt.cz/soubory-ke-stazeni/guide/  
28 http://vyzkum.cz/FrontClanek.aspx?idsekce=759405  
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The Czech Republic has implemented a series of policy measures based on the National 
Innovation Strategy of the Czech Republic 2005-2010 and subsequent National 
Research, Development and Innovation Policy of the Czech Republic for the years 2009 – 
2015. The funding schemes (introduced as from 2007 via structural funds and more 
recently as from 2011 by TACR) target commercialisation and are reinforcing the links 
between academia and business.  
Since the most important KT policies were implemented in the last five years and most 
of the projects are in its initial phase it is too early to evaluate the impact of the policies 
put in place. Therefore, the output indicators (especially those with a long time lag as 
co-patenting or co-publications) are not yet influenced by those policies.  
The major weaknesses of the KT systems are the low absorption capacity of the industry 
due to the structure of the economy (Czech business enterprises tend to perform their 
R&D in-house and the high-technology industries are mostly multinationals performing 
their R&D in the headquarters29) and on the supply side: the traditional low level of 
industry-academia relations, low incentives for researchers to commercialise their results 
and lack of qualified staff in academia to facilitate cooperation.  
The strength of Czech Republic lies in a well-defined IPR law and in a recently 
implemented set of R&D funding programmes by TACR that focus on commercialisation, 
public-private partnerships and supporting collaboration in applied research and 
experimental development. The potential lies in the, for its region, strong performance of 
the Czech public research system and the importance of the medium technology sector 
in the economy.  
Yet, since foreign-owned businesses play a significant role in the innovation system, it is 
a challenge to create tighter and long-term connections between these businesses and 
the public research performers (CDRI 2015). 
The extension of the existing tax credit to contract research in public research 
organisations may increase the volume of privately financed public performed R&D and 
the effects should be monitored in the next years.  
5.8 Regulation and innovation 
Evaluation framework is underdeveloped, there have been no policy actions assessing 
the impact of regulation on innovation.  
5.9 Assessment of the framework conditions for business R&I 
Generally speaking, the framework conditions for business R&I investment are 
improving, however, the progress has been uneven and the success has been at best 
partial so far. A major positive policy shift has been from a system traditionally focused 
on science towards more attention devoted to boosting innovation. Structurally, the 
business sector appears sound; the high- and medium-high-technology sector is large. 
However, there is a lingering gap in innovation performance, as the business sector is 
specialized in low value added segments of value chains. Foreign affiliates are poorly 
integrated in the national innovation system, access to venture capital is limited and 
path-breaking innovation is rare. Innovation activities performed by enterprises are 
focused on the absorption of technologies new to the firm and experimental development 
rather than research and the inflow of young innovation start-up remains small. Given 
the historical separation of science and business, improving public-private circulation, 
collaboration and transfer of scientific knowledge is a constant policy challenge.  
 
                                          
29 http://www.technopolis-group.com/wp-content/uploads/2011/09/1315-International-Audit-
CR_Final-report_Synthesis.pdf  
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6. Conclusions 
6.1 Meeting structural challenges 
The policy mix in the Czech Republic related to the five identified structural challenges is discussed in Table 6: Policy measures addressing 
structural challenges in the Czech Republic., which lists relevant policy actions, assesses their appropriateness, efficiency and effectiveness, 
and provides links to relevant evidence (based on evaluations or empirical analyses). 
 
Table 6: Policy measures addressing structural challenges in the Czech Republic. 
The policy mix in the Czech Republic 
related to the five identified 
structural challenges is discussed in 
Table 9, which lists relevant policy 
actions, assesses their 
appropriateness, efficiency and 
effectiveness, and provides links to 
relevant evidence (based on 
evaluations or empirical 
analyses).Structural challenge 
Policy actions addressing the 
challenge 
Assessment in terms of 
appropriateness, efficiency 
and effectiveness 
Evidence on the impact and 
outcomes of policy actions 
Challenge 1 Improve the research 
excellence and internationalisation 
of Czech science system  
 
updated national RDI policy 
Smart Specialisation Strategy 
several projects supporting the Czech 
researchers in participation in the EU 
programmes 
RETURN programme 
little financial resources spent on 
internationalisation  
lack of regulatory policy measures 
that encourage brain circulation and 
opening up of the Czech research 
system 
new R&I infrastructures may however 
be one of the pull factors 
Analysis of the State of Research, 
Development and Innovation in the 
Czech Republic and a Comparison with 
the Situation Abroad in 2014 (Office of 
the Government of the Czech Republic, 
2015a). 
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Challenge 2 Finalising the governance 
reform and introducing an efficient 
system of allocation of public 
research funding 
 
Plans for the new Ministry for Research and 
Innovation 
draft of the new law on Support for 
Research, Experimental Research and 
Innovation 
adoption of the Civil Service Law 
preparations of a new system of evaluation 
of the results of research organizations and 
their institutional public funding 
The concentration of the RDI policy 
under the new Ministry may increase 
the coordination  
It depends highly on the details and 
its implementation 
The new system of evaluation will not 
be operational before 2017  
 
Analysis of the State of Research, 
Development and Innovation in the 
Czech Republic and a Comparison with 
the Situation Abroad in 2014 (Office of 
the Government of the Czech Republic, 
2015a). 
TA CR project on “Increasing  the 
effectiveness of TA CR in RDI 
intervention and improving RDI public 
administration capacities”. 
Metodika 2013 (CRDI, 2013b). 
Results of the individual national IPN 
Metodika project (Arnold and Mahieu, 
2015; IPN Metodika, 2014 and Srholec, 
2015). 
Challenge 3 Strengthening the public-
private collaboration 
 
national research, development and 
innovation (RDI) policy for 2009-15 
Competence Centres, DELTA and EPSILON 
programmes of TA CR 
TIP and PROSPERITY programme of MIT 
Regional innovation voucher programmes 
Extension of existing tax credits to allows 
for to the purchase of external R&D services 
from research organisations 
The new tax credit in its first year has 
not considerably increased the volume 
of external research services  
Analysis of the State of Research, 
Development and Innovation in the 
Czech Republic and a Comparison with 
the Situation Abroad in 2014 (Office of 
the Government of the Czech Republic, 
2015a). 
Innovation capacity 2014+ (INKA) 
project that maps the national 
innovation landscape. 
Challenge 4 Increasing the 
innovativeness of domestic 
companies 
 
OP EI (2007-2013) funded programmes 
supported SMEs innovativeness 
Extension of existing tax credits to allows 
for to the purchase of external R&D services 
from research organisations 
Czech Invest internationalisation 
programme 
Current policy mix is dominated by 
grant funding with limited efforts 
devoted to support venture capital or 
business angels and revolving funds.  
The new programming period 
introduces a seed funding programme  
 
Analysis of the State of Research, 
Development and Innovation in the 
Czech Republic and a Comparison with 
the Situation Abroad in 2014 (Office of 
the Government of the Czech Republic, 
2015a). 
Innovation capacity 2014+ (INKA) 
project that maps the national 
innovation landscape. 
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6.2 Other structural challenges of the national R&I system 
In addition to the challenges presented in the executive summary of the report, the 
conclusions bring additional challenges of the R&I system in the Czech Republic. 
Stagnating public funding and new large infrastructures 
New large research centres and infrastructural projects with a total amount of subsidy of 
nearly €900m that are under construction and gradually opening with the support from 
the EU Structural Funds represent a great promise for boosting the national research 
output. However, the new projects represent a major funding puzzle, because the EU 
support is for the initial investment only. Later on, wage, maintenance and other 
operating expenses must be covered from other sources. So there is a danger that these 
projects turn from blessing to a curse for the public R&D system, as sizeable opportunity 
costs needs to be resolved. Many of these projects pledged when approved to obtain 
funding from private sources. But this seems to cover only a fraction of their needs and 
their operating costs start draining public R&D funding from the existing facilities. It is a 
major challenge for the RDI policy to integrate these new projects into the national 
system. 
In the meantime, national public R&D funding stagnates. Unless there is a breakthrough 
in the near future, unless the government noticeably expands outlays for R&D, public 
research organisations, including the newly build projects, may end up being 
underfunded. According to preliminary estimates the full operating costs of the new 
research centres and infrastructures might amount from CZK 5b to 10b (€190m to 
385m) per year, which roughly represents as much as one fifth to one third of the 
current public R&D budget. Either the new projects or the existing infrastructure might 
need to shrink; possibly quite significantly. And in the final analysis this can have major 
disruptive impact for functioning of the national RDI system.  
Another critical bottleneck for success of the new large research centre and 
infrastructure projects is availability of qualified human resources, not to mention star 
scientists, on the labour market. Arguably, this can turn out to be a major problem, as 
the expected demand by far exceeds domestic supply in the relevant scientific fields. 
Some of the new staff will have to be poached from the existing infrastructure. Some of 
them, perhaps even their majority, will have to come from abroad. But attracting large 
numbers of top foreign researchers in a relatively short span of time required for 
launching the full operation of the projects is not going to be easy, if one considers the 
above mentioned funding uncertainties, the unresolved rigidities of national labour 
market for researchers, the lingering difficulties with attracting foreign talent and last 
but not least given the fact that the remuneration of scientist in the national system is 
far below the international competitive wage level.  
Policy response 
The SRI and CRDI that has assumed a central role in the new governance system needs 
to be provided with resources that allow them to live up to this task. The GA CR and TA 
CR that have become responsible for competitive funding need to be further supported 
to mitigate the fragmentation of support programs. Several large research infrastructural 
projects, including pan-European infrastructures, are opening or under construction, 
which, if their funding is secured, have a potential to both open new avenues for 
international co-operation and make the system more competitive. 
Skills shortages and rigid labour market for researchers  
According to the assessment of MIT (2011b), because the reform of tertiary education 
remains uncompleted, there has been an unchecked expansion of university graduates, 
the quality of which is however hard to judge. Not much has changed in this respect in 
the meantime.   
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The lack of highly skilled personnel is often cited as not only hampering the quality of 
research in public institutions but even more so as the major obstacle of innovation in 
the private sector. Yet modernization of the higher education system is long overdue, 
the higher education act has been amended seventeen times and it is broadly 
acknowledged that a comprehensive reform of the education system is necessary.  
Human resources management practices in the public sector need to be revised in order 
to reduce the widespread in-breeding, make career progression paths more transparent 
and intensify competition for posts. Horizontal mobility of academic staff is very limited. 
Arnold (2011) noted that management of research groups is underdeveloped, the groups 
tend to be very small, locked into existing research trajectories, lacking 
interdisciplinarity, there is little use of career development plans and only less than 10% 
of researchers are foreign, which is very small proportion by international standards. An 
explicit internationalization strategy of the public research system is lacking. Since the 
higher education reform ended up in doldrums, these caveats remain as relevant as 
ever. Overall, the approach to research human resource management in the public 
sector, including gender issues, is unsystematic. 
Policy response 
Much remains to be done in improving labour market for researchers and in fostering 
gender equality in research, particularly as far as limited mobility, internationalization, 
early career opportunities, rigid recruitment practices and widespread in-breeding are 
concerned. 
Venture capital 
Limited access to external private sources of finance for innovation is perhaps the single 
most important obstacle for improving the innovative performance, particularly in the 
sector of SMEs. Availability of venture capital to support innovative businesses and spin-
off firms trying to commercialize research outcomes is well-known to be extremely low; 
one of the lowest among European countries. A lack of experience among potential 
clients and rather traditional entrepreneurial culture do not constitute a favourable 
environment to venture capital expansion. No tax measures supporting venture capital 
or business angels are in place. 
Policy response 
A major policy shift that needs to be applauded has been from a system traditionally 
based on direct public subsidies to RDI in the business sector towards introducing much 
wider portfolio of measures aimed at alleviating the problem of insufficient availability of 
funding for private R&D efforts, such as the R&D tax credits, loans, guarantees and 
venture capital; which target the type of applicants, including small and new firms, that 
typically do not use the direct support. More measures that go beyond the direct 
subsidies are clearly desirable in the future. 
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Abbreviations 
 
Abbreviation English Czech 
AIE Association of Innovative 
Entrepreneurship 
Asociace inovačního podnikání 
ČR 
API Agency for Entrepreneurship and 
Innovation 
Agentura pro podnikání a 
inovace 
AVO Association of Research Organizations Asociace výzkumných 
organizací 
BERD Business Expenditure on Research and 
Development 
Výdaje na výzkum a vývoj 
v podnikatelském sektoru 
CAS Czech Academy of Sciences, Akademie věd ČR 
CCEG Council for Competitiveness and 
Economic Growth 
Rada pro konkurenceschopnost 
a hospodářský růst 
CERN European Organisation for Nuclear 
Research 
Evropská organizace pro 
jaderný výzkum 
CHEI Council of Higher Education Institutions Rada vysokých škol 
COST European Cooperation in Scientific and 
Technical Research 
Evropská spolupráce ve 
vědeckém a technickém 
výzkumu 
CRC Czech Rectors Conference Česká konference rektorů 
CRDI Council for Research, Development and 
Innovation  
Rada pro výzkum, vývoj a 
inovace 
CZK Czech koruna Česká koruna 
CZSO Czech Statistical Office Český statistický úřad 
EC European Commission Evropská komise 
ELI Extreme Light Infrastructure  Extreme Light Infrastructure 
ERA European Research Area Evropský výzkumný prostor 
ERDF European Regional Development Fund Evropský fond pro regionální 
rozvoj 
ESF European  Social Fund Evropský sociální fond 
ESFRI European Strategy Forum on Research 
Infrastructures 
European Strategy Forum on 
Research Infrastructures 
ESIF European Structural and Investment 
Funds 
Evropské strukturální a 
investiční fondy 
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ESO European Southern Observatory Evropská jižní observatoř 
EU European Union Evropská unie 
EU28 European Union including 28 Member 
States 
Evropská unie s 28 členy 
FP European Framework Programme for 
Research and Technology Development 
Evropský rámcový program pro 
výzkum a vývoj 
FP7 7th Framework Programme 7. rámcový program pro
výzkum a technologický rozvoj 
GA CR Czech Science Foundation Grantová agentury ČR 
GBAORD Government Budget Appropriations or 
Outlays on R&D 
Státní rozpočtové výdaje a 
dotace na výzkum a vývoj 
GDP Gross Domestic Product Hrubý domácí product 
GERD Gross Domestic Expenditure on R&D Celkové výdaje na výzkum a 
vývoj 
HEI Higher education institutions Vysokoškolský sektor 
ICT Information and Communication 
Technologies 
Informační a telekomunikační 
technologie 
IOCB Institute of Organic Chemistry and 
Biochemistry of CAS 
Ústav organické chemie a 
biochemie AV ČR, v.v.i. 
IPO Industrial Property Office of the Czech 
Republic 
Úřad průmyslového vlastnictví 
IPR Intellectual Property Rights Práva duševního vlastnictví 
IS VaVaI Research and Development and 
Innovation Information System of the 
Czech Republic 
Informační systém výzkumu, 
experimentální vývoje a 
inovací 
MEYS Ministry of Education, Youth and Sports 
of the Czech Republic 
Ministerstvo školství, mládeže 
a tělovýchovy ČR 
MIT Ministry of Industry and Trade of the 
Czech Republic 
Ministerstvo průmyslu a 
obchodu ČR 
MRD Ministry of Regional Development of 
the Czech Republic 
Ministerstvo pro místní rozvoj 
ČR 
MoLSA Ministry of Labour and Social Affairs of 
the Czech Republic 
Ministerstvo práce a sociálních 
věcí ČR 
NABS Nomenclature for the Analysis and 
Comparison of Scientific Programmes 
and Budgets 
Nomenklatura pro analýzu a 
srovnání vědeckých programů 
a rozpočtů 
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NIF National Innovation Fund Národní inovační fond 
NIS National Innovation Strategy Národní inovační strategie 
OP Operational Programme Operační program 
OP EI Operational Programme Enterprise and 
Innovation 
Operační program Podnikání a 
inovace 
OP EC Operational Programme Education for 
Competitiveness 
Operační program Vzdělávání 
pro konkurenceschopnost 
OP EIC Operational Programme Enterprise and 
Innovation for Competitiveness 
Operační program Podnikání a 
inovace pro 
konkurenceschopnost 
OP HRE Operational Programme Human 
Resources and Employment 
Operační program Lidské 
zdroje a zaměstnanost 
OP PGP Operational Programme Prague – 
Growth Pole of the Czech Republic 
Operační program Praha – pól 
růstu ČR 
OP RDI Operational Programme Research and 
Development for Innovation 
Operační program Výzkum a 
vývoj pro inovace 
OP RDE Operational Programme Research, 
Development and Education 
Operační program Výzkum, 
vývoj a vzdělávání 
PROs Public Research Organisations Veřejné výzkumné organizace 
R&D Research and development Výzkum a vývoj 
RDI Research, Development and Innovation Výzkum, vývoj a inovace 
RIs Research Infrastructures Výzkumné infrastruktury 
RIS3 Research and Innovation Strategy on 
Smart Specialisation 
Strategie inteligentní 
specializace 
SRI Section for Science, Research and 
Innovations at the Office of the 
Government 
Sekce pro vědu, vývoj a 
inovace vznikla při Úřadu vlády 
S&T Science and Technology Věda a technologie 
TA CR Technology Agency of the Czech 
Republic 
Technologická agentura ČR 
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Annex 2 – List of the main funding programmes 
Name of the 
funding 
programme 
Timeline Budget Target group 
ALFA programme 
of TA CR 
2011-2019 €342m Business 
enterprises 
Competence 
Centres of TA CR 
2012-2019 €231m Business 
enterprises and 
research 
organizations 
EPSILON 
programme of TA 
CR 
2015-2025 €355m Business 
enterprises 
NAKI I program of 
the Ministry of 
Culture 
2011-2017 €70m Research 
organizations 
NAKI II program 
of the Ministry of 
Culture 
2016-2022 €105m Research 
organizations 
National 
Sustainability 
Programme I of 
MEYS 
2013-2020 €325m Large RIs 
National 
Sustainability 
Programme II of 
MEYS 
2016-2020 €234m Large RIs 
OP EIC under the 
MIT 
2014-2020 €7.91b Business 
enterprises 
OP PGP 
administered by 
the Prague City 
Hall 
2014-2020 €0.4b Business 
enterprises and 
research 
organizations 
OP RDE under the 
MEYS 
2014-2020 €3.4b Research 
organizations 
89 
Standard projects 
of  GA CR 
1993-onwards €100m (2015) Research 
organizations 
Support for 
excellence of GA 
CR 
2012-2018 €114m Research 
organizations 
TIP programme of 
MIT 
2009-2016 €440m Business 
enterprises 
TRIO programme 
of MIT 
2016-2021 €136m Business 
enterprises 
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Analysis of the State of Research, Development and Innovation in the Czech Republic 
and a Comparison with the Situation Abroad in 2014 (Office of the Government of the 
Czech Republic, 2015a). 
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(MEYS 2015). 
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